Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news—or the bad—from your shop, and we will feature it here each week.

>Mayo Clinic has announced Matthew R. Callstrom, M.D., Ph.D., as its next president and CEO, taking over for Gianrico Farrugia, M.D., who in May announced plans to step down at the end of the year.

Industry observers note that callstrom, a radiologist, has been with Mayo Clinic since 2002 who is currently medical director for Mayo Clinic Strategy and its AI Program. He's also a member of its board of governors and board of trustees. He's credited for his role in the major nonprofit system's organizational strategy and integration of AI into care.

Sources indicate that farrugia, who has headed Mayo since 2019, intends to stay on through Dec. 31 to ensure a smooth handoff.

>Carl S. Armato, president and CEO of Winston-Salem, North Carolina-based Novant Health, will retire at the end of this year after 15 years leading the system.

Armato joined the nonprofit in 1998 as vice president of finance and operations in its Charlotte and Winston-Salem physician divisions, and held increasing regional and organization-wide leadership roles over subsequent years.

He's credited with boosting access points and unifying Novant's "collection of strong regional organizations into a unified, innovative health system." He also headed substantial growth, with the organization today counting 45,000 employees, 22 hospitals and about 900 total locations.

With his retirement, current Executive Vice President and Chief Operating Officer John Gizdic will become president and interim CEO on Jan. 1, 2027. His resume includes over 30 years of healthcare leadership, including more than 20 with Novant.

> UnitedHealthcare has named Suha Assi as CEO of individual Medicare Advantage, per a LinkedIn post.

Assi previously spent nearly a decade as executive director for Medicare and Retirement in Tennessee, and she previously held roles based in the state for Cigna. She wrote in the post that the "relationships with our teams, providers and communities have shaped how I think about this business and, most importantly, the people we serve.".

In a recent development, "As I step into this national role, I’m excited about what’s ahead for Medicare Advantage," she wrote. "I look forward to working alongside teams and provider partners across the country to modernize how we work together, strengthen relationships, and find upcoming ways to deliver for our members.".

> Daryl Tol, president and CEO of General Catalyst's Health Assurance Transformation Company (HATCo) is stepping down from the role, the venture capital firm's CEO Hemant Taneja shared Tuesday.

Tol had been with the firm for about four and a half years in the wake of his time as president and CEO of AdventHealth's Central Florida Division. During that time, he headed HATCo's partner and advisory network—helping grow it to nearly 40 providers, payers and other portfolio companies—and took the company's top spot partway through 2025. Of note, he helped HATCo close its acquisition of regional health system Summa Health and served as its interim CEO for much of the past year until the appointment of Jennifer Eslinger last month.

Recent findings suggest that tol is being succeeded by Reva Nohria, a founding member of the HATCo team who has been with General Catalyst since 2018. Taneja, in his announcement, stated her work at both organizations has encompassed investment, company creation and strategic partnership, and that she will continue as an investor at the venture capital firm alongside her fresh appointment.

Tol will support a smooth leadership transition and remain in an advisory role, a representative of General Catalyst told Fierce Healthcare.

Recent findings suggest that > Jennifer Shuford, M.D., is leaving her post as deputy director and chief medical officer of the Centers for Disease Control and Prevention on Nov. 12, just four months after joining, according to a Washington Post report that was confirmed by the agency on Tuesday.

The agency told press in a statement that Shuford was departing "to spend more time with family." Her appointment was announced by President Donald Trump in April, and she joined in June.

Shuford is an infectious disease specialist who came to the federal stage from a role as commissioner of the Texas Department of State Health Services and before that, served as the state's chief epidemiologist. Notably, she was credited with heading Texas' response to a measles outbreak last year. Her departure comes as the CDC clashes with state health departments and other public health leaders over its response to a growing national measles outbreak.

Satish Pillai, M.D., is slated to fill the role in the interim as the agency seeks a replacement, the CDC said.

> Johns Hopkins Health System CEO Kevin Sowers is set to retire at the end of 2027.

Industry observers note that sowers has served as president and CEO of the Johns Hopkins system since 2018. He also previously spent more than 32 years as a leader within the Duke University Health System, including eight as CEO of Duke University Hospital.

According to recent reports, the early announcement of his retirement plans gives Johns Hopkins significant time to conduct a search for a successor, with Theodore DeWeese, dean of the medical faculty and CEO of Johns Hopkins Medicine, leading the charge. Sowers will become a strategic adviser to Johns Hopkins to support the transition, the health system noted.

"When I joined Johns Hopkins Medicine in 2018, I made a commitment to the organization and to myself to give 10 years of everything I had to this extraordinary place—to the talented, dedicated people who work here, and the people and communities we serve. And I intend to keep that commitment," Sowers said in a video message.

Sources indicate that > Calley Means, a prominent senior advisor to Health and Human Services Secretary Robert F. Kennedy Jr. closely aligned with the Make America Healthy Again Movement, resigned from his role on Thursday.

The resignation was reported by the Wall Street Journal and confirmed by Means on social media.

Media reports from the past several months described Means' frustrations seeing MAHA policy priorities delayed or blunted by others in the administration, with the journal citing sources describing him as "disillusioned." Still, his time advising the secretary notched several wins for the movement, including overhauled dietary guidelines, steps toward greater food ingredient transparency and loosened restrictions on psychedelics as potential medical treatments.

In a recent development, means wrote in his confirmation post that he still holds "tremendous respect for President Trump and Bobby Kennedy" in their battles against "the entrenched, dark forces in D.C. that profit from Americans getting sick.".

"More policy and cultural change has happened around these goals in the past two years than any time in history—and I know this movement is just getting started," he wrote.

> Premier Health, a five-hospital nonprofit academic system in Southwest Ohio, has appointed Rosanna Morris as its upcoming president and CEO, effective in the first quarter of 2027.

Sources indicate that morris is currently executive vice president and chief clinical operating officer at the University of Texas MD Anderson Cancer Center, and was previously president of Beaumont Hospital-Royal Oak. She is a registered nurse by training and has more than 27 years of health leadership.

In a recent development, she takes over for the retiring Michael Riordan, who has led Premier Health for about half a decade. During that period, he's credited, by the system's board, with stabilizing the system's finances.

> Centivo has added two leaders to its C-suite, the health plan unveiled.

In a recent development, lisa Bielamowicz, M.D., will join the company as chief health officer, while James Parr will step into the role of chief commercial officer. Both are veteran healthcare leaders, Centivo stated.

Bielamowicz has a long career as a physician and health system consultant, and will take on the chief health officer title after advising Centivo's board of directors.

Parr has previously served as a senior adviser to employers at Lockton as well as senior vice president and head of sales at Collective Health. Parr has also held leadership roles at Cigna, per the announcement.

Industry observers note that "There are few leaders in healthcare who have the health benefits strategy knowledge and have built the strong relationships that Lisa and James bring to Centivo," stated Ashok Subramanian, co-founder and CEO of Centivo, in the announcement. "These new leaders put Centivo in a strong position as we launch in new markets and help more employers across the country tackle rising healthcare costs and restore affordability by rethinking their healthcare benefits strategy.".

> Inspira Health CEO Amy Mansue will be retiring at the end of the year, and will be succeeded by current President and Chief Operating Officer Warren Moore, the four-hospital South Jersey system revealed this week.

Mansue will have been at the helm for six years, and is credited by the organization for expanding local care access and championing a culture of wellness among its 7,800-person workforce.

Sources indicate that moore has led Inspira's operations since 2021 and was promoted to president at the top of this year. He has 35 years of industry experience and will most immediately prioritize the opening of a new hospital tower and building upon the system's recent Epic launch.

Sources indicate that “Leading Inspira has been one of the great privileges of my career,” Mansue said in the announcement. “I’m proud of what our team has accomplished and grateful for the trust of our communities. After working alongside Warren for many years, I know his ability to bring people together, navigate complex challenges and understand what our patients and neighbors count on us to deliver. I have every confidence in his leadership of Inspira’s next chapter.”.

> Joint Commission has named Ken Grubbs as its chief operating officer, effective Jan. 1.

In a recent development, grubbs is the first nurse to serve as COO of Joint Commission Enterprise in organization’s history, according to the Oct. 13 announcement. He currently serves as the organization's chief nursing executive and executive vice president of Accreditation and Certification Operations.

He will succeed James Merlino, M.D., who will take over as the organization's president and CEO this coming January.

According to recent reports, > Beth Israel Lahey Health's national leadership search has yielded Peter Shorett as its next president and CEO. His appointment takes effect this coming January.

Shorett is right now the system's senior executive vice president and chief operating officer, and played a role bringing together its Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute for an upcoming strategic collaboration for cancer care. Prior to joining in 2019, he was a senior partner at Chartis.

He'll be taking over for Kevin Tabb, M.D., who in March gave notice to the system's board that he prepares to step down after this year. He'd the role at Beth Israel Deaconess since 2011 and guided the organization through its 2019 merger with Lahey Health.

> WellSpan's Board of Directors has named Laureen Driscoll as the Pennsylvania-based system's new president and CEO.

The executive and registered nurse's appointment will go into effect Jan. 4, 2027. She takes over for Roxanna Gapstur, Ph.D., who announced prepares to retire this past spring.

Driscoll is joining the 12-hospital, $4.7 billion nonprofit from Providence, where she currently serves as chief executive for its south division and oversees 17 hospitals with $10.3 billion of net operating revenue. Prior to that she held roles at MultiCare Health System, Swedish Health System, Le Bonheur Children's Medical Center and Maine Medical Center.

It has been revealed that “She has led complex health systems through transformation while strengthening quality, culture, access and performance," Board Chair Joe Crosswhite stated in the announcement. "Just as key, she leads with purpose and understands that listening to team members, clinicians and communities is essential. The Board is confident Laureen is the right leader for WellSpan’s next chapter.”.

> UnitedHealthcare has elevated Bobby Hunter to the role of president at the insurer.

Hunter wrote in a LinkedIn post that in the latest position he will be tasked with leading the charge on the company's modernization efforts, including investments in technology and other initiatives to simplify the healthcare experience for its members.

Hunter most recently served as CEO of Government Programs at UnitedHealthcare, and has held multiple leadership roles at the insurer dating back to 2011.

"The future we're working toward is one where plans and providers work together more seamlessly, information flows instantly, trust is earned through transparency and accountability, and care teams are able to spend more time focused on patients," he wrote in the post. "To get there, we must continue to deliver on the commitments we make to the people, providers, customers, and communities who count on us every day.".

> Jonathan B. Perlin, M.D., Ph.D., will retire from his roles as president and CEO of accrediting organization Joint Commission on Dec. 31. Current Chief Operating Officer James I. Merlino, M.D., is slated to succeed him.

Perlin boasted three decades of healthcare executive leadership across his career, which included five at the top of Joint Commission. During that period he oversaw a substantial reduction on Joint Commission standards deemed to be burdensome or obsolete, and programs to support healthcare safety issues in low- and middle-income countries. Titles preceding his time at the organization included president of clinical operations and chief medical officer for HCA Healthcare, and the U.S. Department of Veteran's Affairs' under secretary for health.

Perlin will remain a strategic advisor to the group following his retirement, holding the title of president emeritus.

Merlino's career included leadership roles at Cleveland Clinic such as chief clinical transformation officer and chief experience officer, as well as at healthcare performance improvement company Press Ganey.

> Robert C. Garrett, CEO of Hackensack Meridian Health, will retire next year after decades with the organization, including its formative 2016 merger.

In a recent development, garrett is set to step down on June 30, upon which time he'll hold the role of CEO emeritus for a year to help ease the transition. The 18-hospital, nearly $10 billion nonprofit said it prepares to announce his successor before the year's end.

Sources indicate that garrett began his career in the early 1980s at Hackensack University Medical Center, and in 2009 was named president and CEO of Hackensack University Health Network. When the organization merged with Meridian Health in 2016 to form New Jersey's largest health system, he served as co-CEO for two years before taking on the solo mantle.

Alongside the organization's growth to more than 500 patient care locations, Garrett's tenure also marked the opening of the Hackensack Meridian School of Medicine, New Jersey's first new medical school in decades.

"Bob has been the driving force behind HMH's unprecedented growth and transformation, its superior quality, innovation and commitment to building an exceptional workforce," Board Chair Keith Banks stated in a statement. "At the heart of Bob's legacy is his unwavering belief that we must deliver the most innovative and compassionate care to all patients. HMH is solidly positioned for continued growth, and we are profoundly grateful to Bob and extend our warmest wishes to him for this well-deserved next chapter.".

> The Pharmaceutical Care Management Association, the leading lobbying group for the pharmacy benefit management industry, has named CVS Health executive Ed DeVaney as its board chair.

Recent findings suggest that deVaney at the moment serves as president of CVS Caremark, one of the PBM industry's "Big Three" firms. He succeeds Adam Kautzner, president of Express Scripts and Evernorth Health Services, representing one of the other "Big Three" companies.

“The role PBMs play in lowering costs and improving access to prescription drugs for Americans is critically notable,” DeVaney stated in the announcement. “As Board Chair, I’m committed to ensuring PCMA shares our story with policymakers, consumers and employers so they have a full understanding of the work we do to fulfill our commitment to lower drug costs.”.

> UnitedHealth Group has elevated Dan Kueter to serve as the organization's chief commercial officer, per a LinkedIn post.

Recent findings suggest that kueter previously served as the CEO of UnitedHealthcare's commercial business for four years. UHC is the health insurance arm of UnitedHealth Group.

Sources indicate that in the new role, Kueter will be tasked with working across both UnitedHealthcare and Optum to support coordination in product development and innovation, he wrote in the post. He noted he will also collaborate closely with other senior leaders at the UnitedHealth Group level.

"I'm looking forward to working across the company with colleagues at Optum and UnitedHealthcare to help drive our next chapter of growth and innovation, focused on helping make healthcare work better for everyone," Kueter wrote.

In a separate post, Brandon Cuevas revealed that he will succeed Kueter as CEO of UHC's commercial unit. Cuevas most recently served as executive vice president for the national health strategy at Kaiser Permanente, and he previously held multiple leadership roles during a 14-year stint at UnitedHealthcare.

Cuevas stated in the post that he "couldn’t be more excited to rejoin a team that is so capable and committed to making positive change in healthcare.".

> Optum has named Ujjwal Ratan as the latest chief AI officer for its Optum Insight unit, per a LinkedIn post.

Recent findings suggest that in the role, he will be tasked with leading the development of the critical infrastructure that Optum Insight will build its agentic AI toolset on. Ratan has previously held leadership roles at Amazon Web Services and at Oracle, according to his profile.

"Agentic AI only works if the agents have real, connected data to reason over — and few organizations sit across as much of the healthcare journey as Optum does: providers, payers, pharmacy, life sciences and government programs, under one roof," Ratan wrote. "That's exactly the foundation this next wave of AI needs, and exactly why I think Optum is positioned to set the standard for agentic AI across healthcare, not just inside it.".

In a recent development, > Association of American Medical Colleges President and CEO David J. Skorton, M.D., will retire from his post on June 30, 2027, the group confirmed this week. A search for his replacement is right now under way.

Sources indicate that skorton stepped into the role in July 2019 and was kept on by the board in a unanimous 2023 vote. He's credited with guiding the association through the pandemic and overseeing a comprehensive strategic planning process that brought a fresh vision and mission. Prior to joining he served as secretary of the Smithsonian Institution and was president of Cornell University and the University of Iowa.

“He will be leaving the AAMC an even stronger association than when he arrived," Board Chair Michael Waldrum, M.D., mentioned in a statement. "Identifying a visionary leader to guide the association and the academic medicine community into the future will be our next challenge.”.

> Cotiviti, a healthcare infrastructure and data analytics platform, has appointed Erin Schmuker as its chief operating officer.

She enters the role with over 20 years of healthcare leadership, coming directly from a job as president of integrated pharmacies at OptumRx. The fresh position tasks Schumuker with scaling Cotiviti's operating model, bolstering execution and accountability, simplifying operations and bolstering its growth.

In a recent development, “Our opportunity is to connect data and intelligence to the workflows where decisions are actually made and turn that intelligence into action at scale," President and CEO Ric Sinclair said of the appointment. "Erin is a proven operator who understands how to do that. She knows healthcare, she knows our clients and she knows how to bring people, technology and operations together to deliver results. She will help us move faster, operate better and scale Cotiviti for what healthcare needs next.”.

> Kaiser Permanente recently declared that Shaun Smith will be joining as executive vice president and chief people officer, effective Oct. 12.

Smith, who will be reporting directly to the CEO as well as to the president of integrated care and coverage, comes from a chief people and culture officer roles at NewYork-Presbyterian.

> The Blue Cross Blue Shield Association (BCBSA) has named Dan Serrano senior vice president and chief financial officer to oversee the organization’s enterprise financial strategy.

It has been revealed that serrano joins BCBSA after holding leadership roles across the health insurance, provider and value-based care sectors. His experience includes serving as chief financial officer for Aetna's Mid-Atlantic Region and holding senior finance positions at ChenMed, Healthfirst, as well as several other home-based and primary care organizations. He also served as vice president of value and risk-based contracting at Mount Sinai Health System.

“Dan's extensive experience across the healthcare ecosystem, combined with a strong track record of aligning financial performance to operational outcomes, makes him a tremendous addition to our leadership team,” said BCBSA president and CEO Kim Keck in a statement.

>Keck Medicine of USC announced that CEO Rodney Hanners will be stepping down on Sept. 24, alongside a handful of other leadership changes at the system and its affiliated Keck School of Medicine of USC.

Hanners was in the role for six years, a period in which he extended the Los Angeles-based organization's reach into Pasadena and the San Gabriel Valley.

Taking over for him will be Steven Shapiro, M.D., at the moment senior vice president for health affairs, who joined in 2021 from a run as president of the University of Pittsburg Medical Center.

The university noted that it will be trimming the role's responsibilities, reverting supervision of some USC health science schools to the provost "to allow Steve to focus more intensely on elevating our academic medical enterprise.".

Sources indicate that beneath him, the university has also named Chief Clinical Officer David Peng, M.D., as deputy executive vice president for health affairs and Keck Medical Center of USC CEO Marty Sargeant as chief operating officer of the broader system. Both Peng and Sargeant will remain in their prior roles alongside the new responsibilities.

Recent findings suggest that USC's announcement also included word that Keck School of Medicine of USC Dean Carolyn Meltzer is stepping down for a newly introduced role as president of the Radiological Society of North America. Vassilios Papadopoulos, dean of the university's pharmaceutical school, will be filling her role on an interim basis.

>Health tech organization Health Catalyst appointed Simeon Kohl as Chief Executive Officer and President and a member of the company’s Board of Directors, effective September 14.

It has been revealed that kohl most recently served as CEO of Performant Healthcare, a public healthcare tech giant he led through significant strategic and operational transformation, culminating in its sale to Machinify for approximately $670 million. He brings more than 20 years in healthcare, spanning operations, growth and public company leadership. The company’s current CEO and President, Ben Albert, will become Chief Business Officer and will step down from the Board of Directors effective September 13.

During his tenure, Albert led Health Catalyst's strategic priorities and operating initiatives and aligned the leadership team now running the business. He sharpened the manufacturer’s focus on its highest-conviction technologies, positioning Health Catalyst as an AI-forward healthcare intelligence company, executives noted. To support that focus, he led the divestiture of Vitalware, which enabled the company to retire its approximately $160 million credit facility and strengthen its balance sheet.

Recent findings suggest that > The American Medical Association tapped Jennifer Goldsack as senior vice president and inaugural leader of the AMA Center for Digital Health and AI. Goldsack joins the AMA from the Digital Medicine Society (DiMe), a global non-profit organization dedicated to advancing digital medicine to optimize health, where she was both founder and CEO.

A leading voice on the responsible adoption of digital health and AI in healthcare, Goldsack has a record of bringing together evidence, clinical practice, technology and policy to help ensure digital innovations are safe, effective, equitable and capable of delivering meaningful value for patients and physicians, according to the AMA.

"We are at a defining moment for medicine. Digital health and augmented intelligence are rapidly and fundamentally changing how and where care is delivered. For these tools to reach their full potential and be effective for patients, physicians must lead the way in developing and implementing them. Jennifer is the right leader for this moment because she knows how to bring physicians and innovators together and translate that collaboration into real-world impact on patient care," AMA CEO John Whyte, M.D., remarked.

“Reimagining how we care for people in the digital era has been the focus of my career, and we are at an extraordinary moment of opportunity,” Goldsack said in a statement. “We have powerful newly introduced tools at our disposal and a responsibility to make sure we harness them to improve people’s lives. I’m thrilled to join the AMA and work alongside physicians and partners across healthcare. We’re going to set a high bar for what better healthcare looks like in the digital and AI era. And together, we will make it happen.”.

Since its launch last year, the AMA Center for Digital Health and AI has produced key research, including: a survey of AI usage among physicians, showing growing confidence in the technology’s clinical advantages; and an international survey on wearables.

>Teladoc Health appointed Michael Grasher as its new chief financial officer.

Grasher has more than three decades of experience across the insurance and financial services industries, most recently serving as CFO of property-casualty insurance company IFG Companies, according to an Aug. 31 press release.

In a recent development, "Teladoc Health has built a strong foundation with unmatched scale, deep clinical expertise and a global footprint," said Grasher. "I'm excited to work with Chuck [Divita] and the leadership team to build on that foundation and deliver lasting value for the members, clients and shareholders we serve.".

>Johns Hopkins Health Plan has named Daniel Chojnowski as its interim CEO.

Chojnowski has served as the insurer's chief financial officer for the past seven years, according to a post from JHHP on LinkedIn. Former JHHP CEO James Holland departed the organization in mid-August to become president of Medicaid for Humana.

JHHP stated in the LinkedIn posted that Chojnowski will "provide stability and trusted guidance" while it conducts a search for a permanent CEO.

Industry observers note that "Dan believes in leading with courage and compassion," per the post. "He embodies the modern CFO, which has evolved from the number-crunching budget guard to a strategic partner, helping to steer organizational decisions.".

>Wilmington, Delaware-based ChristianaCare welcomed Jenn Schwartz as its latest president and CEO on Sept. 1.

It has been revealed that the fresh top exec came to came to ChristianaCare in 2018 to initially serve as chief legal officer, having previously spent over a decade at Lourdes Health System where she was vice president of legal affairs and general counsel as well as its executive director. She'd already been named as executive vice president and chief strategy officer earlier this year.

Schwartz is taking over for Janice Nevin, M.D., who confirmed earlier this year she'd be retiring after about 23 years at the nonprofit system. She'd held the top roles for a dozen years.

ChristianaCare is a nonprofit teaching health system with three hospitals hosting 1,430 beds as well as a network of primary care and outpatient services.

It has been revealed that janice Nevin, M.D., will end her 12-year run as president and CEO of ChristianaCare on Sept. 1, the system's board confirmed.

Recent findings suggest that she retires after 23 years at the organization, initially joining as its chair of family and community medicine. The physician executive is credited by the board with expanding the system's physical footprint, shepherding "significant investment in historically under-resourced areas" and strengthening its academic partnerships.

It has been revealed that taking up the mantle will be Jenn Schwartz, who was named executive vice president and chief strategy officer at the top of 2026. She came to ChristianaCare in 2018 to initially serve as chief legal officer. Prior to that she spent over a decade at Lourdes Health System, where she was vice president of legal affairs & general counsel as well as its executive director.

According to recent reports, >Insurer Centene has named Bradley Bolivar as its upcoming chief information officer, with the new role taking effect on Aug. 31.

It has been revealed that bolivar succeeds Brian LeClare, who is set to retire in October. He previously served as CIO at Fannie Mae, where he led strategy around technological development, infrastructure, cybersecurity and more. Bolivar brings more than three decades of technology leadership experience to the role at Centene, according to an announcement from the company.

Sources indicate that "We are entering a newly introduced era where data, technology and AI are not just business enablers, but strategic capabilities that shape how we operate, innovate and create value," CEO Sarah London said in the announcement. "Brad's proven ability to solve complex technology challenges will position Centene to deliver simpler, better health experiences and improved outcomes for the nation's most underserved populations.".

>Elevance Health has named Patrick Fox, M.D., as president of Carelon Behavioral Health.

Industry observers note that fox's background includes more than three decades of experience in clinical psychiatry, behavioral health, public health and health plan leadership, the firm stated in an announcement. He most recently served as president Elevance-affiliated plan Wellpoint Upcoming Jersey.

Fox also previously helmed the company's Colorado Medicaid plan, per the announcement. Fox's fresh title is effective immediately.

"Patrick brings a rare combination of experience as a practicing psychiatrist, behavioral health leader and health plan executive,” mentioned Kristy Duffey, president of Carelon Health, in the announcement. “He understands the challenges facing behavioral healthcare from the clinical, operational and system perspectives.".

"That breadth of experience will be invaluable as we work to improve access, strengthen connections across the healthcare system and deliver better outcomes for the people we serve," said Duffey.

Patrick Gillespie, regional vice president for state affairs at Elevance Health, has been named as Fox's successor as Wellpoint Newly introduced Jersey president, the manufacturer noted.

>Providence St. Joseph Health has named a upcoming chief financial officer.

Kevin Smith will take the CFO seat on Oct. 26, according to an announcement from the health system. As CFO, he'll oversee Providence's "inancial strategy, planning, capital allocation and operational performance," the system remarked.

Smith will join Providence from SSM Health, where he right now serves as CFO. He's also held leadership roles in finance at Luminis Health, Lehigh Valley Health Network, Universal Health Services and the University of Pennsylvania Health System.

“Kevin is a highly respected healthcare finance leader with a strong track record of improving performance, guiding complex organizations and positioning health systems for long-term success,” remarked Erik Wexler, CEO of Providence, in the announcement. “His experience, judgment and commitment to Mission-driven stewardship will be invaluable as we continue strengthening Providence for the future.”.

>Accolade executive Shantanu Nundy will join Humana as its new chief medical officer.

Sources indicate that nundy, M.D., currently serves as executive vice president of care delivery and chief health officer at Accolade, a healthcare navigation and care delivery organization. He'll step into the role at Humana on Aug. 31, according to an announcement from the company.

Nundy also held leadership roles at Evolent Health, and has provided council to a number of organizations on digital health and AI, including the Food and Drug Administration and World Bank. He continues to practice medicine, including primary care a community health center and hospital-based medicine through a local health system.

Nundy will report to Humana CEO Jim Rechtin as part of the enterprise leadership team.

Sources indicate that "Clinical excellence is at the heart of Humana’s vision to be a leading consumer healthcare organization, and I am thrilled to welcome Dr. Nundy as our upcoming chief medical officer," Rechtin noted in the announcement. "I am confident Shantanu’s experience at the intersection of clinical outcomes, technology and the consumer experience will advance our efforts to simplify the path to care and help the people we serve achieve their best health.".

Industry observers note that >St. Jude Children's Research Hospital has named Charles W.M. Roberts, M.D., Ph.D., as its next president and CEO, effective Jan. 1, 2027.

Recent findings suggest that he presently serves as director of the St. Jude Comprehensive Cancer Center, having joined the organization in 2015 to fill the post. The pediatric hematologist/oncologist has headed the center's five research programs, pushed the center to its best scores in National Cancer Institute rankings and has his own body of medical research that has paved the way to FDA-approved and investigational cancer therapies.

His appointment follows the February announcement from St. Jude that its current leader, James R. Downing, M.D., planned to step down. The organization said it conducted "an extensive international search" before selecting a successor from within.

>CVS Health has declared changes to its board of directors, including the addition of JPMorgan Chase executive Teresa Heitsenrether.

In a recent development, heitsenrether brings nearly forty years of experience in financial leadership to the board, and currently serves as the chief data and analytics officer at JPMorgan. She will join CVS' board on Nov. 18.

“Teresa’s extensive experience leading complex global businesses and driving technology-enabled transformation will be invaluable as CVS Health continues to innovate on its path to become a consumer focused, health technology firm,” CVS CEO David Joyner noted in the announcement.

In addition, Larry Robbins has departed CVS' board as of Aug. 13. Robbins has served on the board since 2024, with roles on its Audit and Public Policy and External Affairs Committees.

Robbins is the CEO of Glenview Capital Management.

>Drew Asher, chief financial officer at Centene, will step down from the position in December, the company announced on Monday.

Sources indicate that asher intends to retire from Centene at the end of 2027, per the announcement. He will take the year between stepping down as CFO and retirement to support the transition and ongoing strategic priorities.

Sources indicate that chris Neczypor has been tapped as Asher's successor and will join the firm in September, according to the release. Neczypor is a veteran executive who most recently served as CFO at Lincoln Financial, which provides life insurance, annuities and retirement solutions.

Recent findings suggest that he had multiple leadership roles at Lincoln after joining the organization in 2018, Centene said. Neczypor spent more than a decade in financial services prior to Lincoln, including a stint as an equity research analyst at Goldman Sachs.

"Chris brings a proven track record of strengthening financial performance, optimizing operations and creating long-term shareholder value," Centene CEO Sarah London noted in the announcement. "Just as importantly, he is a collaborative, values-driven leader who understands how to build strong teams and drive meaningful impact.".

"Our organization will benefit from his expertise, energy and perspective as we deliver on Centene's next phase of transformation and growth," London mentioned.

Asher has served as CFO at Centene since 2021.

>Humana has named a upcoming executive to lead its growing Medicaid business.

The insurer stated Monday that James Holland will join the organization as senior vice president and president of Medicaid effective Aug. 17. In the role, he will oversee plans that cover 1.6 million people across 11 states, according to an announcement.

According to recent reports, holland most recently helmed Johns Hopkins Health Prepares, overseeing Medicaid, Medicare and other government plans. He has also held leadership roles at Elevance Health, Amerigroup and WellCare Health Plans.

Holland will report to Aaron Martin, president of insurance at Humana.

According to recent reports, “Medicaid is an notable part of how we deliver on Humana’s purpose, helping some of the most vulnerable populations access the care and support they need to achieve their best health,” Martin stated in the announcement. “J.P. brings deep expertise leading government-sponsored healthcare prepares and maintaining strong relationships with state and provider partners.".

"His experiences and insights will be invaluable as we continue to grow our Medicaid business and better serve our Medicaid members," Martin mentioned.

>Amid the health system's financial strengthening project, Tufts Medicine CEO and CFO have transitioned away from the tech giant.

The current CEO, Mike Dandorph, will step down on September 30, which is also the conclusion of the 2026 fiscal year. He will continue to work towards a transition that ensures Tufts Medicine continues its upward trajectory.

Phil Okala, the COO of Tufts Medicine, will serve as Acting President and CEO. Phil has held multiple leadership roles at Tufts Medicine, and other health systems, including Penn Medicine. With the Board’s full support, he hopes to “focus on guiding Tufts Medicine to greater clinical, operational and financial success.”.

Andrew DeVoe, the current Executive Vice President and CFO, has also decided to depart Tufts Medicine, after playing an key role in improving the organization's performance. Soon, Tufts Medicine expects to begin a nationwide search for his replacement. As for right now, Greg Kruse, Tufts’ Vice President of Strategic Operations and Analytics Intelligence, will assume responsibility for future budget planning.

Dandorph mentioned “Serving as President and CEO of Tufts Medicine and working closely with such extraordinary people has been a distinct privilege these past six and a half years. I am proud of what we have accomplished together and am grateful to the amazing physicians, nurses, researchers, learners, staff and leaders whose commitment to our mission has inspired me every day. I believe this transition is in the best interest and right time for Tufts Medicine. In the coming months, I will work closely with Phil Okala to ensure a thoughtful and orderly transition that best positions the organization for its next chapter and future success.”.

It has been revealed that >Summa Health announced on August 3 that Jennifer Eslinger will join as the health system's new President and CEO beginning on September 21. She will succeed Daryl Tol, the current Acting CEO, who has led the organization following its acquisition by Health Assurance Transformation Manufacturer (HATCo).

Recent findings suggest that eslinger brings more than two decades of leadership experience; most recently serving as President and COO of Rochester Regional Health. At Rochester Regional Health, she led the $4.2 billion health system through significant transformation and strategic growth.

According to recent reports, "Jennifer is an accomplished healthcare leader with deep experience driving operational and clinical excellence, embracing innovation and creating a culture of curiosity and continuous improvement,” said Kate Walsh, Chair of Summa Health’s Board of Directors. “She has both the judgment and values to build on Summa Health's strong foundation while accelerating our impact in the communities we serve and helping shape the future of healthcare.”.

>Jaewon Ryu, the chief executive officer of Risant Health at Kaiser Permanente, has decided to step down from the role to focus on his family. Dale Maxwell, former president and CEO of Presbyterian Healthcare Services, will serve as interim CEO during the national search by the board.

"Jaewon has been instrumental in turning the vision for Risant Health into reality," said Greg Adams, chair and chief executive officer of Kaiser Permanente and chair of the board of Risant Health. "He built an exceptional leadership team, established the organization's operating model, and positioned Risant Health to help more communities benefit from value-based care.”.

It has been revealed that ryu served as Risant Health’s inaugural CEO, establishing its operating model and recruiting the initial leadership team. Key moments in his tenure include the addition of both Geisinger and Cone Health as well as meaningful clinical and operational improvements.

The interim CEO, Dale Maxwell, brings over 24 years of executive leadership experience at Presbyterian Healthcare Services, Newly introduced Mexico's largest nonprofit integrated health system.

Sources indicate that "This leadership transition reflects thoughtful planning, not a change in strategy," Adams noted. "Kaiser Permanente and Risant Health will continue to advance their mission to help leading community-based health systems deliver high-quality, value-based care. We are confident in the organization's leadership, its momentum, and its future.".

>Paul Smith and Frederick Crawford were elected as latest members of the Humana board, effective immediately.

Smith currently serves as the chief commercial officer at Anthropic, PBC, leading commercial strategy and go-to-market operations. Prior to joining Anthropic, he was chief commercial officer and president of global customer and field operations at ServiceNow and held senior leadership roles at Salesforce and Microsoft.

In a recent development, crawford also brings significant experience to the Humana board, having spent more than 30 years in the insurance and banking industries. Before his retirement in 2024, Crawford was president and chief operating officer at Aflac. He also sits on the Board of Webster Financial Corporation as a member of both the Audit and Risk committees.

According to recent reports, “We are pleased to welcome Paul and Fred to the Humana Board. Paul has deep experience guiding the world’s largest enterprises in responsibly adopting technology and AI at scale along with a strong track record in product development and client service, while Fred brings broad industry experience and financial expertise focused on disciplined capital allocation and risk management,” said Humana Chairman of the Board Kurt J. Hilzinger.

Sources indicate that >Centene unveiled that Kenneth A. Burdick has retired from the company's board of directors, effective July 28, and that Paul J. Diaz has been appointed to the board, effective immediately.

In a recent development, burdick joined the Centene board of directors in January 2022, offering insight that drew upon his long-standing leadership in healthcare. He served as executive vice president of products and markets at Centene and before that was the chief executive officer of WellCare Health Plans.

Recent findings suggest that diaz is currently a managing partner at Cressey & Manufacturer, a private investment firm focused on cultivating high-quality healthcare firms. Before joining Cressey, he was president and CEO of Myriad Genetics Inc., as well as CEO of Kindred Healthcare. He has also served on the board of healthcare organizations, such as DaVita and PharMerica.

According to recent reports, "Ken has been a valued member of our Board. His deep industry expertise, strategic perspective, and commitment to improving healthcare have made a meaningful impact on Centene. On behalf of the Board, we thank him for his service and wish him all the best in retirement," mentioned Frederick H. Eppinger, Chair of Centene's Board of Directors. "We are also pleased to welcome Paul Diaz to the Board. His extensive healthcare leadership experience, public company governance expertise and record of guiding organizations through growth and transformation will bring valuable perspective as Centene continues to advance its strategy and serve its members.".

In a recent development, >Siemens Healthineers announced on July 30 that João Seabra will succeed John Kowal as president and head of the Americas for Siemens Healthineers, effective Oct. 1, 2026. He is currently the head of Siemens Healthineers Enterprise Services.

Industry observers note that seabra joined Healthineers in 2001, and from 2015 to 2018, he led the Western Europe and West Africa regions. In his most recent role as head of enterprise services, he quadrupled its revenue over the last eight years.

“We would like to thank John for his many years of successful service and outstanding commitment to Siemens Healthineers, first within our Varian business and later as President and Head of our Americas business. We are very pleased to appoint João Seabra as our new President and Head of the Americas. Under his leadership and thanks to his innovative thinking, Siemens Healthineers paved the way in our industry by creating Value Partnerships of increasing scope and impact with key customers,” remarked Darleen Caron, Member of the Managing Board at Siemens Healthineers with responsibility for the Americas and Chief Human Resources Officer.

>PayZen, an AI-driven patient affordability platform, has announced that Jingwei Wu will serve as senior vice president of engineering.

According to recent reports, prior to joining PayZen, Wu led the engineering team behind the LinkedIn Jobs Marketplace, expanding it to reach millions more job searchers. He’s also been part of engineering leadership teams at both Twitter and Tinder.

In his fresh role at PayZen, Wu will lead the manufacturer’s engineering organization, overseeing platform architecture, AI infrastructure and product engineering.

“Healthcare affordability is one of the biggest challenges facing patients and providers today, and PayZen is proving that AI can fundamentally improve how people access and pay for care,” Wu stated.

>Sarah Bast was appointed as the chief marketing officer of OptimizeRx, a healthcare technology solutions provider.

In a recent development, she brings over two decades of experience from companies including Publicis Health Media, Lilly, Bayer, Johnson & Johnson and AstraZeneca. In these roles, she developed significant expertise in point of care media strategy, which she will bring to her role at OptimizeRX.

As CMO, Bast will lead Optimize Rx’s marketing strategy and continue strengthening the tech giant's relationships with healthcare marketing agencies.

Industry observers note that "Sarah's decision to join OptimizeRx speaks to both the strength of the business we've built and the tremendous opportunity ahead," mentioned Steve Silvestro, Chief Executive Officer, OptimizeRx. "She has spent her career helping life sciences brands solve complex marketing challenges and understands firsthand how healthcare marketers can reach providers more effectively. As OptimizeRx enters its next phase of growth, her strategic vision and deep understanding of the market will help us strengthen our customer relationships and accelerate the development of solutions that improve healthcare engagement.".

According to recent reports, >Matt Swafford has been named executive vice president and chief financial officer of Peace Health, succeeding Ric Magnuson, the current interim CFO. He will join the tech giant on September 21 from St. Charles Health System, where he right now serves as CFO and senior VP of strategy and finance.

Swafford brings over 35 years of experience in nonprofit health system finance, helping health systems navigate change and invest in patients.

It has been revealed that sarah Ness, PeaceHealth president and chief executive officer, mentioned, “We are creating a stronger PeaceHealth, one that is easier for patients to navigate, better connected for caregivers and positioned to meet the needs of our communities well into the future. Matt has shared with me that he sees every financial decision through that human lens, which makes him a strong fit for our Mission and our commitment to put people first.”.

>Hannah Alphs Jackson, M.D. will join Availity, the nation’s largest real-time health information network, as the company's first chief medical officer.

Availity stated in a statement that it created the CMO role “to ensure clinical expertise is injected throughout the company's strategy, innovation, and customer solutions.” This is significant as the healthcare industry and Availity continues to become dependent on automation and AI, executives said.

Before joining Availity, Alphs Jackson held roles in physician and payer leadership, where she integrated value-based care models with clinical operations. In her new role as CMO, she will guide the responsible usage of emerging technologies, as part of Availity’s clinical strategy.

“Dr. Jackson brings a rare combination of clinical expertise, provider perspective, payer experience and strategic vision,” stated Russ Thomas, CEO of Availity, in a statement. “As healthcare continues to evolve, it's critical that we have strong clinical leadership guiding how we integrate automation and AI capabilities to support the entire healthcare system – and ultimately improve the entire experience.”.

>Clinical AI assistant startup Nabla revealed the appointment of Brian Manning as its upcoming CEO to lead the company's next phase of growth.

Manning joins Nabla from Bamboo Health, where he served as president and chief revenue officer and helped scale the company to more than $140 million in revenue. He also assisted in the growth and development of PatientPing and Zocdoc.

Sources indicate that as Nabla continues to expand, supporting more than 190 healthcare organizations and 100,000 clinicians, Manning will spearhead the company’s scaling efforts. His more than 20 years of experience accelerating growth will ensure that Nabla continues to be adopted across the healthcare industry, executives mentioned in a press release.

"Healthcare organizations are looking for partners that can deliver real value today while helping them prepare for the future of AI. Nabla has built an exceptional foundation and has earned the trust of clinicians and healthcare organizations. The opportunity now is to accelerate that momentum, expand our reach, and further establish Nabla as the clinical AI partner of choice for healthcare organizations across the world,” said Manning.

>Aptarro, a firm that provides healthcare revenue cycle management software solutions, hired Paul Wiley as chief growth officer.

According to recent reports, wiley’s appointment comes at a significant time for Aptarro as the organization continue to scale its engine for denial prevention and reimbursement intelligence. Wiley has more than two decades of executive leadership experience spanning healthcare technology, enterprise software, AI and travel technology, according to the company, and he has been tapped to steer the company through its current commercial growth.

Most recently, he served as chief commercial officer at Avodah, and prior to that, he founded Opargo, an AI-powered healthcare scheduling manufacturer. His experience will ensure that Aptarro continues to effectively address the persistent and costly problem of denials, executives said.

It has been revealed that "As reimbursement continues to grow more dynamic, healthcare organizations need technology that evolves alongside it. We're building the leadership team to support that mission," mentioned Jeff Diamond, Aptarro CEO. "Paul's experience will be instrumental as we continue expanding our platform and defining the future of reimbursement intelligence.".

Industry observers note that >The Pharmaceutical Care Management Association (PCMA) added two senior public affairs leaders to its team. Mackay Jimeson will join PCMA as Vice President of Coalitions, and Christine Rex will join as Senior Director of State Communications.

Jimeson joins PCMA from Patients Rising, where he was served as Executive Director, expanding the organization’s national influence and strengthening its role in health care policy. In his new role at PCMA, he will lead PCMA’s coalition strategy and third-party partnership engagement efforts.

Rex will oversee state campaigns and coalition communications, while working closely with PCMA's member companies.

“Bringing this level of talent reflects PCMA’s commitment to strategically meeting the needs of this moment,” remarked David Marin, President and CEO of PCMA. “The pharmacy benefit manager industry has been transformed and is more responsive than ever, and we are entering a new era of advocacy at PCMA. MacKay will use his unique experience advocating for patients to strengthen our coalition partnerships and build broader alliances for the industry and the 289 million patients we serve. Christine is a battle-tested communicator who expertly navigates state legislative debates. Our team is deeper and more dynamic having them at PCMA.”.

>Vanderbilt Health has chosen David C. Miller as the successor to Jeff Balser as President and CEO and Dean of Vanderbilt University School of Medicine.

Recent findings suggest that miller is at the moment serving as Chief Executive Officer of Michigan Medicine and Executive Vice President for Medical Affairs for the University of Michigan and will assume the role at Vanderbilt on January 1, 2027. Earlie this year, Balser announced plans to retire on December 31, after serving Vanderbilt in leadership roles for nearly two decades.

Miller’s experience at the similarly sized Michigan Health uniquely prepares him to become Vanderbilt Health’s new leader, the health system stated. Miller’s selection as the new senior leader for Vanderbilt Health and Vanderbilt University School of Medicine finalizes an extensive national search by the VH Board of Directors to identify Balser’s successor.

As Chief Executive Officer, Miller will be responsible for shaping the future strategic direction of Vanderbilt Health and maintaining the scholarly activities shared by the Medical Center and University.

Recent findings suggest that “From an incredibly strong field of applicants, Dr. Miller’s personal warmth, prior leadership experiences, and commitment to organizational culture stood out. David has presented an exciting vision for advancing the Medical Center’s missions and is the ideal candidate to succeed Dr. Balser. We look forward to welcoming David, his wife, Inge, and family to the Nashville community,” stated Edie Carell Johnson, Chair of the VH Board of Directors.

In a recent development, >Aledade appointed Darren Thayne as chief technology officer and hired Josh C. Mandel, M.D. as chief scientist. Thayne and Mandel will bring deep expertise in enterprise scale and open data standards to the tech giant, Aledade said.

Leveraging their combined experience, Aledade will further integrate advanced AI into its platform.

Thayne joins Aledade from Domo, where he spent 15 years leading its technology team, as founding technology leader, chief technology officer and executive vice president of product. He was responsible for breakthrough technology and deployment of AI-based tools that were central to customer experience.

Dr. Mandel, who is both a physician and software engineer, joins Aledade from Microsoft research, where he helped build open standards such as FHIR (Fast Healthcare Interoperability Resources). His work will focus on external interoperability and data exchange efforts, as well as AI strategy.

Industry observers note that “AI raises the stakes on that alignment. Deployed inside fee-for-service, it accelerates billing. Deployed inside our value-based care model, it accelerates health. Daren and Josh have built infrastructure and open standards at national scale, and they're joining us to make sure that the value created by AI in healthcare flows to patients and practices,” stated Farzad Mostashari, M.D., co-founder and CEO of Aledade.

>Rad AI announced that Leonard Law will join the company as Chief Product Officer. Law's hiring comes at a pivotal moment for the radiology reporting market, as health systems and radiology practices shift from legacy reporting software to AI-native radiology workflow platforms, the company stated.

Law joins Rad AI from Primer, an enterprise AI platform, where he served as chief product officer. Previously, he was head of product at Coinbase and he also spent nearly a decade at Google Cloud and YouTube.

His appointment builds on other recent executive additions and debuts, including Rad AI's next-generation speech recognition technology and appointment of David Leonard as COO. Law will work closely with Jeff Chang, M.D., co-founder and president of Rad AI, to build on the firm’s radiologist-led product foundation and help scale the next generation of AI-native workflow solutions.

Industry observers note that >Laura Kaiser, the president and CEO of SSM Health, has been elected by the American Hospital Association (AHA) Board of Trustees as its chair-elect designate. She will serve as chair-elect in 2027, eventually becoming chair of AHA and the top elected official of the national organization that represents America’s hospitals.

In a recent development, since 2017, Kaiser has been a crucial part of SSM Health, which serves serves millions of patients across Missouri, Illinois, Wisconsin and Oklahoma. As part of her work with SSM Health, she transformed the health system's telehealth capabilities and unveiled a partnership with Siemens Healthineers to expand access to care and train healthcare workers.

Industry observers note that she also serves on several other boards, including Greater St. Louis Inc., Merit Medical and Navitus Health Solutions.

“I look forward to the opportunity to serve, continuing to advocate for America's hospitals and health systems to advance solutions that work for everyone. The AHA's vision of a society of healthy communities, where every person has the potential to live a healthy life, is one I have pursued throughout my career,” Kaiser said in the announcement.

>Ted Holden was named as the Vice President of Client Success for Collective Health, an independent third-party administrator that combines administration, cost management and care.

Prior to this appointment, he served as Head of Strategic Partnerships and Network Strategy at Noom and Chief Growth Officer at Catapult Health. During his early career, he spent over 20 years at BlueCross BlueShield of Texas.

Holden will lead a team delivering a stellar experience to Collective Health’s self-funded employer clients, drawing on his relationships across the healthcare industry and his robust experience, the company stated.

Recent findings suggest that “I’ve spent my career on the carrier side, the digital health side, and everywhere in between, and what Collective Health has built is genuinely different,” Holden noted in a statement. “One unified foundation that brings together administration, cost management, and care navigation, with incentives aligned with employers. I’m excited to help our clients understand what’s possible and make sure they’re getting every ounce of value from it.”.

It has been revealed that >Brian S. Kim, M.D. has been named the first vice president and chief biotechnology officer at Northwell Health, as well as head of intellectual asset management at the Feinstein Institutes. He will also join the department of dermatology as a professor at Northwell Health.

It has been revealed that the Feinstein Institutes is home to Northwell Health’s research center, and it serves as the largest health care provider and private employer in Upcoming York State. Kim joins Feinstein from the Icahn School of Medicine at Mount Sinai, bringing his expertise in dermatology, medical research and biotechnology.

His work has led to significant clinical advances, including the design of pivotal clinical trials that resulted in two first-in-class U.S. Food and Drug Administration-approved treatments for atopic dermatitis and prurigo nodularis. He has founded three biotech companies, including Alys Pharmaceuticals, and authored over 190 peer-reviewed publications.

Kim will continue to advance Feinstein Institute’s groundbreaking research on electric stimulation to treat disease, including work on nerve stimulation implants that could potentially treat Crohn’s disease and other inflammatory conditions.

Recent findings suggest that “Dr. Kim’s appointment reflects our commitment to transforming bold research into better outcomes for our patients,” said John D’Angelo, M.D., Northwell’s president and CEO. “With his leadership, we can better translate breakthrough science and pioneer the future of medicine while staying grounded in our mission to produce knowledge to cure disease.”.

Recent findings suggest that >Anita Girard, R.N., of the American Nurses Association\California, was elected by representatives of the American Nurses Association (ANA) as the upcoming president representing the interests of more than 5 million nurses. Her two-year term of service will begin on January 1, 2027.

Sources indicate that girard, a Doctor of Nursing Practice (DNP), will lead ANA’s implementation of the organization's 2026-2030 strategic strategy, and its Board of Directors. She presently serves as vice president of the American Nurses Association and most recently served as the president of the American Nurses Association\California. Prior to leading these associations, she was chief nursing officer and VP of nursing at Cedars-Sinai Medical Center in Los Angeles, California.

“I am deeply honored to be elected to serve as the next president of the American Nurses Association and to help lead this organization into its next chapter,” Girard mentioned in a statement. “For more than 30 years, I have served this profession across clinical, operational, executive, and association leadership roles, and that experience has reinforced one enduring belief: nurses must be supported, respected, and empowered in every setting where they are educated and practice.”.

It has been revealed that >The University of Oklahoma’s academic health system (OU Health) has named Jonathan W. Curtright as the new president and CEO, effective July 1, 2026. Richard P. Lofgren, M.D., OU Health’s inaugural president and CEO, confirmed his retirement earlier this year and Curtright will be his replacement.

Recent findings suggest that curtright has been chief operating officer of OU Health since August 22, and under his leadership, the system saw an annual revenue increase from $1.9 billion to a projected $3.7 billion in fiscal year 2026. Admissions also increased 22.3% percent and outpatient clinic visits statewide reached more than 1 million, reflecting higher patient volumes and service intensity as opposed to acquisitions.

He was also responsible for program expansions, including investments in pediatric health, cancer centers and neonatal intensive care.

According to recent reports, OU Health board of directors Chair G. Rainey Williams Jr. mentioned, “Jonathan has been instrumental in helping advance OU Health’s mission and strategic vision during a period of extraordinary growth. He understands the unique responsibilities of an academic health system and has demonstrated the leadership, operational expertise and long-term vision needed to guide OU Health into its next chapter. The board is confident in his ability to build upon the strong foundation established under Dr. Lofgren’s leadership.”.

>Christopher O’Connor, the CEO of Yale Latest Haven Health System (YNHHS), will be leaving after 14 years with the organization.

Recent findings suggest that he will serve as a special advisor to the chair of the Board of Trustees during the transition, and the board will also be conducting a CEO search over the next months. Pamela Sutton-Wallace, the current president of YNHHS, will serve as acting CEO, effective immediately.

In a recent development, O’Connor joined YNHHS after leading the acquisition of the Hospital of Saint Raphael, and during his time with Yale, he oversaw multiple hospital integrations and strategic collaboration with Yale Medicine. YNHHS has been well positioned by O’Connor to open the Adams Neurosciences Center in 2027, which is the largest strategic project in the history of the academic health system, according to the release.

“We are extremely grateful to Chris for his commitment to the System and many years of service,” said Mary Farrell, chair of the YNHHS Board of Trustees. “He has worked tirelessly to serve our patients and communities during the pandemic with exemplary care and results, and leaves YNHHS in a strong and successful position as we continue to offer the very best care to every one of our patients.”.

Industry observers note that >The Medical University of South Carolina (MUSC) announced that their president, David J. Cole, will retire in June 2027 after 13 years. He initially joined MUSC in 1994, and Cole will remain a professor and surgical oncologist with the system.

An extensive nationwide search for Cole’s successor will be led by former board chairman and sitting trustee James Lemon, D.M.D, and conclude next spring.

It has been revealed that during his tenure, he secured support for the construction and opening of Shawn Jenkins Children’s Hospital and Pearl Tourville Women’s Pavilion, as well as the Jean and Hugh K. Leatherman Behavioral Care Pavilion in Florence. Cole also maintained MUSC’s U.S. News & World Report accolade as the “Best Hospital” in South Carolina.

"To have had the opportunity to lead and serve this remarkable institution has been one of the great privileges of my life," Cole noted in a statement. "MUSC stands today as one of the nation’s leading academic medical centers, a testament to what can be achieved when people are united in service to patients, students, families, communities and one another.”.

>Alice Rigdon of Mayo Clinic in Florida will join Deaconess Health System as senior vice president and chief financial officer, effective this fall. She will succeed Cheryl Wathen, who is retiring after more than 36 years with Deaconess, including 16 years as the system's CFO.

At Mayo Clinic Florida, Rigdon drove capital and finance transformation initiatives, including standardization, automation and workforce development. Prior to joining Mayo Clinic, she served as VP of finance at SCL Health's Saint Joseph Hospital in Denver and as director of outpatient strategy and development and CFO of Piedmont Medical Center in South Carolina.

Wathen was initially named senior vice president and CFO of Deaconess in 2010, after serving as manager of internal audit, manager of finance, CFO of The Women's Hospital and controller of Deaconess Health System.

"What I am most proud of is the people I have hired and mentored who have excelled in their roles and will be the leaders that take Deaconess into the future,” Wathen noted in a statement.

According to recent reports, >The American Hospital Association named Steve Walsh as its upcoming president and CEO, taking over for the retiring Rick Pollack. Walsh comes from a similar role at the Massachusetts Hospital Association, and will stay there until the appointment takes effect this fall. Read more here.

Recent findings suggest that >Symplr, a provider of enterprise healthcare operations software, appointed Andrew Langford as Chief Financial Officer, effective immediately. As symplr continues to scale its investment in AI-powered innovation, Langford is poised to help drive the manufacturer’s next phase of value creation and operational excellence, the company said. He succeeds Tom Fink, who has served as interim CFO since early 2026, and will ensure a smooth leadership transition.

Langford was previously an executive vice president at Zelis, where he oversaw financial strategy, treasury, enterprise pricing and operational planning for the healthcare and financial technology firm. Prior to Zelis, he spent nearly a decade at Global Payments, Inc. in a series of progressively senior finance leadership roles.

Sources indicate that “Andrew brings the strategic perspective, financial discipline and operational acumen that will help guide symplr through its next phase of growth,” said Venkat Kavarthapu, symplr CEO, in a statement. “His expertise in scaling global organizations, executing strategic transactions and partnering across the business will be instrumental as we continue to invest in AI-powered innovations that reduce complexity, enhance care quality and deliver value for our customers.”.

>President Donald Trump announced on his social media platform, Truth Social, that Chris Klomp has been tapped to serve as Deputy Secretary for the Department of Health and Human Services.

Klomp, who heads the Department of Medicare at the Centers for Medicare & Medicaid Services, has made a rapid rise through the agency to a potential role as its second-in-command. The Deputy Secretary post has been vacant since February, when Jim O'Neill departed the agency. At the same time, Klomp was elevated to a senior adviser to HHS Secretary Robert F. Kennedy, Jr.

In the Truth Social post, Trump noted that Klomp's career trajectory "proves that he is a potential STAR." He said that he, Kennedy and CMS Administrator Mehmet Oz, M.D., chose Klomp as a nominee "together.".

"Chris is a Strong and Inspiring Leader and a Highly Successful Entrepreneur," Trump wrote in the post. "Everywhere Chris goes, he earns TRUST. He is a person of principle, and is deeply committed to serving the AMERICAN People — and fixing our broken Healthcare System.".

>Michael Wagner, MD, the President and Chief Executive Officer of Care Latest England Health System (CNE), will step down as CEO and transition to become Chair of the Board of Directors. The Board has begun the process to search for CNE’s new CEO and President, aiming to have new leadership by early 2027.

Dr. Wagner joined Care Fresh England in 2022, and he was responsible for implementing an Epic electronic health record program and a strategic planning initiative. Wagner also secured $100 million in capital in order to expand the system and restored the organization to positive operating performance. He intends to remain President and CEO until the successor has been selected and onboarded, which will ensure a smooth transition.

Industry observers note that gary Furtado, the current Chair of the CNE board, will continue to serve in his role until the transition is complete. Furtado said in their release that: “Mike’s leadership has been transformative for Care New England. His vision, commitment, and steady leadership have strengthened the organization clinically, strategically, and financially. The Board is grateful for his service as CEO and pleased that he will continue to support the organization as Board Chair.”.

According to recent reports, >Rush University System for Health and Rush University Medical Center announced today that Omar Lateef, D.O., president and CEO, intends to retire from his role in June 2027. The Rush Board of Directors also announced that it will begin a national search for the next system leader in early fall.

It has been revealed that lateef has been connected to Rush for over 25 years, completing his fellowship training in Pulmonary and Critical Care Medicine at Rush University Medical Center in 2005 and joining the faculty afterwards. In 2019, he became the chief of pulmonary and critical care medicine, and in 2022, he became the CEO of the system.

Industry observers note that in these leadership positions, Lateef led Rush’s response to the COVID-19 pandemic, earning both him and the system widespread recognition. Under Lateef’s leadership, Rush University Medical Center’s standing among the nation’s premier academic medical centers has grown significantly, including repeated placement on the U.S. News & World Report Honor Roll, according to the organization. He helped establish national benchmarks for quality and safety through Rush’s leadership in Vizient quality outcomes.

“Omar’s career at Rush exemplifies extraordinary dedication to our mission and our patients,” said William Downe, Chair of the Rush University System for Health Board of Directors. “From his arrival as a fellow more than two decades ago to his service as President and CEO, he has helped shape Rush into the organization it is today.”.

Recent findings suggest that >Madeline Bell, the CEO of Children’s Hospital of Philadelphia (CHOP), will retire on October 1, 2026, after almost 40 years with the organization. CHOP's current president, Joseph (Joe) Mitchell, M.D., will succeed her.

Sources indicate that bell, who has served as CEO for 11 years, announced her intent to retire in 2024, beginning the search for CHOP’s fresh leader. In April 2025, Mitchell joined CHOP and began to work closely alongside Bell, the Board, and their C-suite to ensure a smooth transition.

According to recent reports, mitchell brings over 20 years of healthcare leadership experience, including roles at both Boston Children’s Hospital and Franciscan Children’s Hospital. At Franciscan, he secured approvals and capital to support its 10-year institutional master plan. Prior to this, he worked at McKinsey & Company for 14 years, including seven years as partner.

Recent findings suggest that “Joe brings a fresh perspective, a patient-first approach and a strong strategic mindset," Greg Davis, chairman of CHOP’s board, remarked in the announcement. "We are confident he will guide CHOP into its next chapter with continued excellence and impact.”.

>Kevin Leahy, the CEO of nonprofit Catholic healthcare ministry Franciscan Alliance, will step down from his position on December 31.

Industry observers note that he prepares to stay with Franciscan as an internal consultant until the end of 2027, to facilitate the leadership transition. Following this, he will retire after 48 years of service at Franciscan.

"It is our responsibility to continue Christ’s ministry in our Franciscan tradition by serving the needs of all who seek healing of body, mind and spirit, especially the most vulnerable among us," Leahy remarked in a statement.

It has been revealed that >MultiCare Health System unveiled its CEO, William (Bill) Robertson, will retire on Dec. 31. The current president, Florence Chang, will become the health system's new President and CEO beginning on Jan.1 2027.

Chang and Robertson will continue to work closely together this year to ensure a smooth transition.

In a recent development, robertson has been part of the MultiCare team since 2014, serving as CEO since 2022 and growing MultiCare to become the largest community-based nonprofit health system in the region. He was largely responsible for their expansion across Washington state, creating a comprehensive and clinically integrated system there.

It has been revealed that chang joined MultiCare in 2006 as senior vice president and chief information officer. She has won multiple accolades for MultiCare, including the HIMSS Davies Organizational Award of Excellence. As executive vice president and chief operating officer, she was responsible for the smooth operation of eight hospitals and over 180 clinics.

Industry observers note that “On behalf of the Board of Directors, I want to thank Bill Robertson for his extraordinary leadership and the lasting impact he has had on MultiCare,” said John Wiborg, board chair for MultiCare Health System, in the announcement. “As MultiCare moves forward into this next chapter, the board has full confidence and trust in Florence Chang as she steps into this leadership role. She is a highly effective servant leader with a great passion for MultiCare’s mission, as well as a deep knowledge of the organization’s capabilities and areas of opportunity.”.

>Komodo Health changed its leadership structure as part of the manufacturer's long-term vision for enterprise-wide adoption of AI. Miles Ennis, former chief operating officer, has been appointed as president, while co-founder, Web Sun, will assume the role of co-CEO. They will both work alongside co-founder and CEO Arif Nathoo, M.D.

Ennis initially joined Komodo Health as chief revenue officer in 2024, leading one of the strongest growth periods in tech giant history and accelerating the adoption of Marmot, which is an AI-native platform that builds evidence sets for complex questions, according to the company. In his new role as President, he will continue to scale Komodo's growth opportunities, while aligning innovation with industry needs and strengthening the company’s execution.

In the manufacturer's recent press release, both Sun and Nathoo emphasize that healthcare is moving in the direction of full AI adoption, as opposed to the previous phase of AI experimentation. Sun further states that “Miles has consistently demonstrated the ability to connect strategy, product innovation, customer needs, and execution, a capability that becomes even more important as AI reshapes what is possible in healthcare and Life Sciences.".

It has been revealed that >Jamie Sharp, M.D. and Chris Rigg have joined Strive Health's executive team. The value-based kidney care firm tapped Sharp as its new chief medical officer and Rigg joined as chief financial officer. Sharp will oversee the clinical strategy, while Rigg will assist with scaling the business and deploying new AI technologies.

Sharp previously served as chief medical officer at dementia care platform Rippl, and she held senior executive roles at Aetna, naviHealth and Evolent Health. "Drawing on this experience, Sharp will advance clinical outcomes and care model transformation at Strive," organization executives mentioned in a press release.

Rigg most recently served as chief financial officer and senior vice president of commercial health benefits at Elevance Health, supporting more than 32 million consumers across individual and employer group projects. In his early career, he was a healthcare-focused analyst at Deutsche Bank, Susquehanna International Group and Merrill Lynch.

"Sharp and Rigg’s leadership will help accelerate Strive’s ability to deliver measurable outcomes for patients, providers and payers as Strive continues to expand its value-based kidney care model nationwide," Chris Riopelle, CEO and co-founder, noted in a statement.

Recent findings suggest that >R1, a healthcare revenue management leader, unveiled that Eric Tagliere will join the company as Chief Information Officer. During his over 30-year career, Tagliere has served as Chief Technology Officer for both Humana and Marriott, leading both companies’ technological integration.

Sources indicate that at Humana, Tagliere spearheaded operations to advance their cloud and technology modernization strategy, according to the organization’s press release. At Marriott, he was a key part of the technological integration of Starwood Hotels & Resorts and oversaw digital engineering. In his latest role at R1, Tagliere will assist in R1’s transformation “from a labor-first to technology-first paradigm.” This work is in line with R1’s pioneering Healthcare Revenue Operating System that combines AI with human intelligence to improve the revenue cycle.

In his statement, Chief Executive Officer of R1, Joe Flanagan states, “I am pleased to welcome Eric to R1 as we continue to strengthen our technology capabilities and position the Company for long-term, AI-enabled growth. With more than three decades of experience leading large-scale technology transformations, Eric is a proven leader who brings unique insights and capabilities to advance our technology strategy.”.

Sources indicate that >Travis Moore will join Xealth, a leader in digital health, as the firm's upcoming Chief Revenue Officer. As CRO, Moore will lead Xealth’s revenue organization, expanding their overall footprint in healthcare, according to their recent press release.

Moore brings over 20 years of health technology leadership experience to Xealth, in fields including product management, marketing and sales. In previous roles, including as SVP of Sales & Growth at Kyruus, he oversaw the addition of commercial teams, revenue growth, organization and execution. In his statement, Moore claims “Xealth has a unique opportunity to provide the missing link for digital health expansion, and now with the backing and broader vision of Samsung Health, I’m looking forward to helping our commercial team scale that impact.”.

>During an induction ceremony at the Healthcare Financial Management Association (HFMA) conference, Matthew Cox officially assumed the role of National Chair. HFMA is a non-profit, nonpartisan organization that strives to offer finance professionals in healthcare spaces with guidance.

Sources indicate that as chair, Cox aims to prioritize collaboration and community building to take on healthcare industry challenges. As CFO of Corewell Health, Cox focuses on making care and coverage affordable while maintaining financial integrity of the system, the organization said. C. Ann Jordan, president and CEO of HFMA states that this expertise, and his “dedication to supporting healthcare leaders nationwide make him exceptionally well suited to serve as HFMA’s next chair.”.

Other executives joining HFMA as Board officers and members are as follows:.

Chair-Elect Marcus Whitney, CHFP, co-founder and CEO of Jumpstart Health.

Secretary-Treasurer Scott R Harwig, CPA, CMA, MBA, Executive Vice President and CFO at BJC Health System.

Board Members (three-year term ending in 2029).

Ash Shehata, Managing Director at Impact Advisors.

Michele Napier, Senior Vice President and Chief Revenue Officer for Orlando Health.

Kevin Smith, CFO of SSM Health.

Jeremy Friese, MD, Founder, Chairman, and CEO of Humata Health.

>Morrison Foerster, a top global law firm, confirmed the addition of two new partners in the firm's Intellectual Property Litigation Group and Life Sciences + Healthcare divisions. Ching Lee Fukuda and Tom Broughan provide nearly five decades of combined experience in patent and trade secret law regarding medical devices, medtech, life sciences, and technology.

Fukuda previously served as Sidley Austin’s co-leader of global IP litigation and a member of their Global Life Sciences leadership team. She was a partner there for over a decade, winning trial victories before district courts, the Federal Circuit, the International Trade Commission and the Patent Trial and Appeal Board. Fukuda’s work has been recognized by many legal publications, and she was named Patent Lawyer of the Year by Women in Business Law Americas in 2024.

Broughan also joins Morrison Foerster from Sidley Austin, bringing similar experience in IP litigation in district court. In Patent Trial and Appeal Board proceedings, he regularly serves as a lead counsel and has been recognized in Best Lawyers for his work there. The two of them have worked together extensively, according to Morrison Foerster’s press release.

Brian Nash, the chair of Morrison Foerster’s global Intellectual Property Group, notes that Fukuda and Broughan will continue to work together to “enhance and expand our IP litigation footprint.”.

In a recent development, >According to a recent LinkedIn post, Maynd Jolly has been named the CFO of Health Care Delivery for CVS Health. Previously, he worked as CFO and SVP of Growth and Client Partnerships at enGen, and Global CFO of Digital Oncology and Head of Finance at Enterprise Services.

> The American Medical Association has named Sandra Adamson Fryhofer, M.D., as its next president-elect, a decision that comes as the current holder of that title, Willie Underwood III, M.D., takes the place of outgoing president Bobby Mukkamala, M.D.

Fryhofer is a board-certified internal medicine physician with a full-time practice in Atlanta and an adjust associate professor of medicine role at Emory University School of Medicine. She's been a member of the group's House of Delegates since 1999, elected to its Board of Trustees in 2018 and served as the board's chair from 2022 to 2023. She also previously had leading roles at the American College of Physicians as its president and a member of its Board of Regents.

Industry observers note that fryhofer has been a prominent voice in public health. Alongside serving as the AMA's liaison to the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (CDC ACIP), she has been a regular medical correspondent and contributor for CNN and Medscape.

“Medicine is at its best when we put patients first and remain guided by science and evidence," Fryhofer said in the organization's announcement. "We have a tremendous opportunity to improve public health and ensure every patient has access to high-quality care. I am honored to serve as president-elect as we continue that work together.”.

Sources indicate that the AMA's members elect presidents for one-year terms that turnover every June during its Annual Meeting of the House of Delegates. Underwood, a urologic surgeon with expertise in healthcare disparities and policy, was selected in last year's vote and will begin his term this week.

>Rajneesh Kumar is joining Staritas, an independent health supply chain data provider, as the tech giant's upcoming Chief Technology Officer. It marks the company’s first major leadership hire and demonstrates Staritas’ commitment to investing in decision making technology, according to a press release.

Staritas’ CEO, Emmet O’Gara states: “Raj has the technical depth and operational leadership to accelerate our AI investments, expand our platform, and advance our mission of helping healthcare leaders make every choice clear, and we are thrilled to be adding him to our team.” His twenty-five years of experience in enterprise technology transformation leadership will allow him to accelerate product innovation that assists organizations in their informed decision-making process.

It has been revealed that >Transcarent, an access platform for high quality, affordable medical and pharmaceutical care, unveiled that Anjali Jameson joined the manufacturer as Chief Product Officer. In previous roles, she led product and technology teams at Rally Health, UnitedHealth Group and Apple, building digital health products that serve employers, payers and providers.

Jameson will utilize her background to oversee Transcarent’s WayFinding platform, which is “the first agentic AI-powered health and care platform designed to guide users through the healthcare system and take action.” This platform aims to improve quality of care for self-insured employers by offering an easily navigable healthcare experience.

In the firm’s press release, Glen Tullman, CEO of Transcarent, noted that, “She understands how to use AI to do what technology has done in every other industry - deliver higher quality at dramatically lower costs - and how to bring that to health and care.” This move will position Transcarent to continue leading in AI powered healthcare solutions, executives noted.

Recent findings suggest that >AdvancedMD, a cloud-based healthcare software provider, appointed Stephanie Cho as Chief Marketing Officer and unveiled Move Care Forward, a brand platform that gives independent practices tools to reduce administrative work and focus on patient care. Cho’s appointment and this launch will power accelerated investment in the company, AdvancedMD said in a press release.

Cho formerly worked as the vice president of marketing at Simple Practice, leading customer marketing for their mental health care platform and delivering a multi-million-dollar revenue impact. She has previously held marketing leadership roles at Wells Fargo and American Express, and she holds an MBA from Stanford Graduate School of Business.

“She’s the right leader to make sure every practice in ambulatory care knows what AdvancedMD can do for them — and that Move Care Forward isn’t a tagline, it’s how we operate,” notes AdvancedMD CEO Amanda Sharp.

Sources indicate that >Ben Nielsen will succeed the retiring CEO of Ridgeview Medical Center, Mike Phelps. Ridgeview, a nonprofit regional health care system that serves part of the Twin Cities, initiated a comprehensive process in early 2026 to select the organization's fresh President and CEO.

According to the Board, in this process, they “recognized Ben’s strategic capabilities, operational leadership and his experience developing and implementing many of Ridgeview’s key business priorities.” He has held multiple leadership roles at Ridgeview from 2010 onwards, including as chief operating officer, where he coordinated the health system’s ambulatory operations across campuses and locations.

Recent findings suggest that mike Phelps will remain with Ridgeview through Jan. 2, 2027, to assist with a smooth transition. He emphasizes that “Ben’s character and appreciation for our strong culture — centered on ensuring everyone we care for matters here — will help sustain our commitment to caring for our communities while keeping Ridgeview a strong, healthy organization where staff can invest their valuable time and careers.”.

>Anant Vinjamoori, M.D., will serve as the latest Chief Medical Officer for the Hims brand, an online comprehensive care platform. With more than a decade of clinical and executive experience, Vinjamoori brings expertise in preventive and longevity care that incorporates diagnostic and therapeutic technologies.

Prior to joining Hims, he founded Next Generation Medicine, which combines medical education with AI technology to assist clinicians with incorporating longevity medicine. He is also the author of several peer-reviewed publications, and Vinjamoori received his MD from Harvard Medical School and his MBA from Harvard Business School.

Recent findings suggest that the Global Chief Medical Officer of Hims & Hers, Pat Caroll, indicates “Dr. Vinjamoori has been at the leading edge of helping people feel great at every stage of life, and he brings the perfect combination of clinical expertise and dedication to consumer access to Hims & Hers.” His work will shape Hims’ clinical backbone in the sexual health, hormone health, dermatology, weight loss, and mental health fields, according to the organization’s press release.

It has been revealed that >The Melanoma Research Alliance (MRA), a nonprofit funder of melanoma research, revealed that beginning on July 1, 2026, Stephanie Kauffmann will serve as the organization's Chief Executive Officer. Joining MRA in 2022 as Chief Operating Officer and President, she oversaw growth in research investment and philanthropic and corporate partnerships.

Recent findings suggest that kauffman will replace Marc Hulbert, Ph.D., who is leaving MRA to become CEO of the National Kidney Foundation. The Board recognized Dr. Hulbert’s contribution to strengthening the position of MRA as a melanoma research funding leader, and notes that he will continue to serve as a member of MRA's Scientific Advisory Panel.

According to Debra Black, Co-Founder and Chair of the Melanoma Research Alliance, in Kauffman’s previous role she “has earned the trust and respect of our Board, staff, researchers, donors, and patient community through her leadership, vision, and unwavering commitment to our mission.” Under Kauffman’s leadership, MRA plans to continue expanding their investments in groundbreaking rare melanoma research and patient centered innovation to improve conditions for patients worldwide.

>Ardent Health President and CEO Marty Bonick "has stepped down to pursue other opportunities," the for-profit health system announced this week. Replacing him immediately is Dave Caspers, who had been serving as chief operating officer.

According to recent reports, bonick helmed the company through a string of challenges, including the COVID-19 pandemic and its 2024 initial public offering. Board Chairman Mark Sotir noted that work in the announcement and remarked the former head executive had positioned Ardent "for sustained long-term growth and help[ed] build a strong foundation as the Company continues to navigate industry headwinds with a focus on disciplined execution. We wish him all the best in his next chapter.".

Recent findings suggest that caspers, meanwhile, joined Ardent in March 2025 but has spent decades in operational roles. These include senior healthcare leadership positions at Walmart Health, Banner Health and Target. He's spent the past year in the weeds of Ardent's IMPACT (Improve Margins, Performance, Agility and Care Transformation) Program.

In a recent development, "Over the past year, I have had the privilege of working closely with Marty, whose leadership and guidance have been instrumental in laying the solid footing on which Ardent Health now stands," remarked Caspers, who has also joined Ardent's board. "Today, Ardent Health and our best-in-class team are well-positioned to accelerate our next phase of growth, and I am eager to build on this momentum with a continued focus on delivering high-quality care to the communities we serve.”.

>Drew Altman, M.D., founding president and CEO of the influential heath policy research, polling and news nonprofit KFF, will retire from his roles at the end of this year.

He formed the organization in 1990 out of the Henry J. Kaiser Family Foundation, and has since expanded its scope to include the country's largest newsroom focused on health policy, KFF Health News.

“With two small grandkids in Sacramento and Atlanta and another on the way, after what will be almost 37 years of very hands-on leadership since I founded KFF, and with KFF at the apex of its effectiveness, and the opportunity for a perfect transition, the clock in my head is telling me it’s time,” Altman stated in this week's announcement.

Following the recommendation of a search committee, KFF has unanimously appointed two in-house leaders to take on Altman's titles: Larry Levitt, currently executive vice president for health policy, as CEO; and Mollyann Brodie, Ph.D., currently executive vice president and chief operating officer, as president.

Sources indicate that the pair have a combined six decades of experience at KFF already under their belt, and will take on board positions with their new roles. They will work with Altman to ensure a smooth transition through the end of the year, officially stepping into his shoes in January 2027.

>Visory Health, a prescription savings program, has promoted two executives: Alexandra Robertson to chief growth officer, and Brittney Tierce to chief technology officer.

Recent findings suggest that robertson started as vice president of growth, driving the organization's expansion and presence in more than 38,000 pharmacies nationwide. She will now oversee growth strategy, partnership development and program innovation.

"Visory is positioned to redefine what prescription access looks like for underserved populations, making affordability and access the norm, not the exception," Robertson said in a press release shared in advance with Fierce Healthcare.

It has been revealed that meanwhile, Tierce created the tech underlying Visory. She will now drive the tech strategy tech giant-wide, including security, tech and AI innovation.

"Technology should be a bridge, not a barrier," Tierce mentioned in the announcement. "My focus is raising that bar continuously by creating smarter systems, faster delivery and infrastructure that scales access to the communities we serve.".

In a recent development, > Healthcare AI organization Abridge brought on board a new chief technology officer, San Oo, as it expands its technology into more health systems. Oo joins Abridge after previously holding leadership roles at Slack and Notion, two popular workplace and productivity software tools.

At Notion, Oo set engineering goals and directions, with a strong focus on reliability, developer velocity and agentic engineering, according to an Abridge press release. At Slack, he helped build the engineering organization during the "hypergrowth years" that defined modern workplace collaboration. Earlier, he served as CTO at ShopBack, a unicorn in the Asia-Pacific region. He was also a founding member of two companies that were later acquired: Mumbo Inc., acquired by LinkedIn in 2012, and Astro Technology, acquired by Slack in 2018.

It has been revealed that "The platforms San helped build altered the texture of work with thoughtful technology and exceptional craft that facilitate human connection,” Shiv Rao, M.D., CEO and founder of Abridge, mentioned in a statement. “Healthcare is the next industry that needs that kind of care and platform-level rethink, and San is the rare engineering leader who's done it multiple times.".

Recent findings suggest that abridge is rapidly scaling its AI scribe and clinical decision support technology. It is live in more than 270 of the largest health systems in the U.S., including Duke Health, Johns Hopkins Medicine, Sutter Health and Yale Latest Haven Health. The platform will support more than 100 million patient conversations in 2026.

According to recent reports, "I've spent my career building products and platforms that people love to use that are secure and reliable. Now I want to do the same for healthcare, where the stakes are even higher,” Oo stated in a statement. “Abridge already sits at the center of the most notable moment in healthcare, the conversation between a clinician and a patient. The opportunity now is to extend that intelligence across the entire system.".

> Alignment Healthcare has unveiled multiple leadership changes that it states will power up the company for long-term growth.

In an announcement, the insurtech said that CEO John Kao has also been named as chairman of the board, allowing him to work more closely with board members. Alongside this shift, previous board chair Joseph Konowiecki has been named vice chairman and as Alignment's executive vice president of corporate affairs.

In the role, Konowiecki will provide critical enterprise-wide leadership as the team looks to build scale, Alignment mentioned in the announcement. Konowiecki is a veteran healthcare executive.

In a recent development, mark Kent will also join Alignment as president of its management services organization, or MSO. Kent brings experience in value-based care and primary care to the position, having previously held leadership roles in Humana's primary care division, Alignment said.

Alignment Healthcare has also tapped Shane Hochradel as its newly introduced chief operating officer. Hochradel has held leadership positions at Elevance Health, Highmark and UnitedHealth Group, per the announcement. All three executives will report to Kao.

“Together, these leadership additions strengthen Alignment’s operating model and position the tech giant well for sustained growth and execution at scale,” Kao remarked in the announcement.

> Highmark Health has tapped former UnitedHealth Group executive Heather Cianfrocco as its new chief operating officer.

Recent findings suggest that in her time at UHG, Cianfrocco held multiple key leadership positions, including serving as CEO of Optum where she helmed its three core business lines: Optum Rx, Optum Health and Optum Insight. She was most recently the healthcare giant's executive vice president of governance, compliance and information security.

She announced her departure from UnitedHealth in March.

"We have boldly mentioned that we want to be one of the organizations that solves the complex and fragmented health care system," said David Holmberg, Highmark Health CEO, in the announcement. "Heather is a seasoned, innovative health care leader who has a broad national lens, and her skills will be critical as we strive to further expand the reach of our mission and accelerate the work we are doing to transform our industry.".

Highmark President Karen Hanlon will continue to lead the company's Living Health initiative, per the announcement.

> Emad Rizk will join Premier, Inc. as its fresh president and CEO, the firm announced.

It has been revealed that rizk, M.D., comes to Premier from healthcare analytics company Cotiviti, where he also served as president and CEO. In the new role, Rizk will be tasked with continuing to drive Premier forward as it seeks to support better patient outcomes at a lower cost.

“I’ve seen healthcare from every angle, and I know what is at stake for Premier’s members,” said Rizk in the announcement. “Providers are being asked to do more with less in an environment that is only getting more complex. Premier has the scale, the data and the relationships to help providers make better decisions and deliver better outcomes. This is where we can make the greatest impact.”.

> Alexander Billioux, M.D., is joining the executive team at Cityblock as chief health officer.

Billioux spent the last five years at UnitedHealthcare, where he most recently served as chief medical officer for government programs. He also held leadership roles at the Center for Medicare and Medicaid Innovation and the Louisiana Office of Public Health.

In his latest role, Billioux will spearhead Cityblock's clinical strategy and care operations as the tech giant looks to continue advancing its care model.

"I've always been passionate about ensuring that the opportunity for quality healthcare is accessible for all populations. For a large part of my career, that has meant supporting members who face increasing financial and social challenges," Billioux stated in the announcement. "Joining Cityblock allows me the opportunity to leverage ground-breaking technology to empower teams to deliver high-quality, comprehensive care that improves the health of vulnerable members.".

> Blue Shield of California has named Hayley Park as its new senior vice president and chief pharmacy officer.

In the role, Park will lead the charge on Blue Shield's Pharmacy Care Reimagined initiative, which eschews traditional pharmacy benefit management models for an "unbundled" approach that leans on multiple solutions to offer different elements of the benefit.

Blue Shield said Park brings more than 25 years of experience to the position, and that she served most recently at Kaiser Permanente Northern California as president of pharmacy operations and services.

“What drew me to Blue Shield is that it’s a mission-driven nonprofit health plan that’s committed to improving member health and their lives—not just lowering costs for medications,” Park said. “As pharmacy care shifts to support individuals in a more connected and personalized way, I am excited to join an organization that is transforming healthcare to make it more accessible for everyone.”.

According to recent reports, janice Nevin, M.D., will end her 12-year run as president and CEO of ChristianaCare on Sept. 1, the system's board announced.

According to recent reports, she retires after 23 years at the organization, initially joining as its chair of family and community medicine. The physician executive is credited by the board with expanding the system's physical footprint, shepherding "significant investment in historically under-resourced areas" and strengthening its academic partnerships.

According to recent reports, taking up the mantle will be Jenn Schwartz, who was named executive vice president and chief strategy officer at the top of 2026. She came to ChristianaCare in 2018 to initially serve as chief legal officer. Prior to that she spent over a decade at Lourdes Health System, where she was vice president of legal affairs & general counsel as well as its executive director.

It has been revealed that > Maui Health CEO Lynn Fulton will be stepping down on May 3 after a little over two years in the Hawaiian health system's top role. She prepares to return to central Illinois to be closer to her family, according to the announcement that promises a leadership transition initiative "in the coming days.".

Fulton is credited with overseeing improved quality and financial stabilization during her time at the three-hospital nonprofit system.

> Tenet Healthcare Chief Information Officer Paola Arbour aims to retire at the end of this year, according to a recent regulatory filing from the for-profit hospital and ambulatory surgical center chain. She's been in the role since 2018, and plans to stick with the organization in a part-time, non-executive role through April 1, 2028 "to provide continuing transition services and support.".

> Samuel Marchio was named senior vice president, chief government relations and policy officer at Ascension, per a social media post. He comes off a 15-year stint at Elevance Health (initially Anthem), where most recently served as regional vice president of federal government affairs.

In a recent development, > Stephen Taluja was named chief mission officer of Providence, a role that tasks him with aligning the Catholic nonprofit system's charity and service aims with ongoing strategic and organizational transformation. The appointment takes effect on June 29.

Taluja comes to the organization from a Bon Secours Mercy Health, where he is currently chief sponsorship and formation officer. He's been there in various roles since 2014, and before that led multicultural parish ministries.

> Addiction treatment provider Birches Health has added former Cigna Chief Medical Officer Doug Nemecek, M.D., to its advisory board as a senior adviser. As a senior adviser, Nemecek will work closely with the leadership team at Birches as it evolves its clinical and payer engagement strategies.

Nemecek's experience in the payer market will be key to informing this work, according to an announcement.

In a recent development, > Oraida Roman has been named as Aledade's newly introduced chief commercial officer, the company revealed on Wednesday. In the role, she will be tasked with leading the team's strategy around national health initiative partnerships.

Roman brings 25 years of experience to the role, and will spearhead work around 200 contracts including Medicare Advantage, Medicaid and commercial plans.

> WellSpan Health President and CEO Roxanna Gapstur, Ph.D, is calling it a career after more than eight years at the nonprofit system's helm.

It has been revealed that wellSpan's board declared the intends April 6, sharing that Gapstur will continue in the role until the transition to a replacement is complete. No specific or expected timeline was given, other than sharing that a national search for that latest executive has begun.

According to recent reports, the system, which employs 23,000 people, has grown under her tenure from eight hospitals to 12, and from $2.5 billion of revenue to $4.7 billion. Its footprint has also expanded from five counties to 12 across Pennsylvania and northern Maryland, now reaching more than 1 million patients.

In a recent development, the announcement credits Gapstur with bringing "clear strategic direction" that focused on quality, safety, patient experience and employee engagement. That approach brough national recognitions and designations to its facilities, plus new developments like a genomic program bringing precision medicine into patient care.

> Centene Corporation has created two new positions to lead key segments of its insurance business.

According to recent reports, the organization noted in an announcement that it has named Daniel Finke as group president for markets and commercial and Michael Carson as its group president for Medicare and specialty. Both executives will report to CEO Sarah London, per Centene.

Finke is an experienced insurance executive and will be tasked with overseeing and scaling the tech giant's Medicaid and commercial segments. He joins the insurer from Convey Health Solutions, where he was CEO, and has also previously served as president of Aetna at CVS Health.

Sources indicate that carson, meanwhile, will take on an expanded role in overseeing Centene's Medicare Advantage, Part D, dual-eligible and specialty populations. He joined the tech giant as CEO of WellCare in 2024, and previously held leadership roles at Bright Healthcare and Harvard Pilgrim Health Care.

London stated in the announcement that the shift recognizes Carson's significant contributions to the organization and the experience that Finke brings to the table in driving operations forward.

"Their collective experience will be instrumental as we continue to strengthen performance across the portfolio and deliver sustainable, profitable growth," she said.

> Cory Mead was named CEO of HCA Florida Palms West Hospital, effective March 30. With more than a decade in leadership roles with HCA Healthcare, Mead most recently served as CEO of HCA Florida Woodmont Hospital.

> Elevance Health unveiled a slew of latest leadership appointments within its Health Benefits business and Carelon, the unit leading services such as pharmacy benefits, behavioral health and value-based care enablement.

Sources indicate that kristy Duffey was named president of Carelon Health. The nurse practitioner-turned-executive recently helped scale care models and boost performance at Optum and CINQCARE. She'll be taking over for Peter Haytaian, who's slated to leave the role on May 4 to focus on family commitments but will remain through the end of the year as a special advisor to ease the transition, the tech giant previously confirmed.

Aimée Dailey was appointed president of government business. She's already attributed with playing "a pivotal role" in expanding Elevance's government programs, and will now have responsibilities covering Medicare, Medicaid, Federal Government Solutions and Group Retiree Solutions.

Additionally, Will Feest, at the moment chief operating officer for Carelon, will be adding president of Carelon Insights to his title card; Darrell Oliveira was named chief financial officer for Carelon; and Jeff Plante, previously president of Carelon Insights, was dubbed chief financial officer for the Health Benefits segment.

Industry observers note that elevance said the latest leaders will help expand and scale Carelon, which reaches over 90 million healthcare consumers. The Health Benefits segment provides coordinated solutions to more than 45 million Elevance members.

> Kurt Small was named president and CEO of CareFirst BlueCross BlueShield, effective May 4.

Recent findings suggest that small is currently president of Medicaid at Elevance Health, where he has been for nearly seven years. He has over 25 years of healthcare leadership experience, including roles at Blue Cross and Blue Shield of Minnesota, Highmark and Aetna.

At Elevance, he oversaw a Medicaid business with about 8.5 million members. CareFirst, meanwhile, is a nonprofit with 3.5 million members primarily living in the District of Columbia, Maryland and Northern Virginia. It has been without a permanent top executive since last September, with Ja'Ron Bridges serving as interim president and CEO.

> Barclay Berdan, CEO of Texas Health Resources, will retire in September after four decades at the 29-hospital nonprofit.

The executive stepped into his role in 2014, and was credited by the organization in its announcement release for guiding the system "through some of the most complex public health challenges in modern U.S. history while leading significant transformation across the organization’s clinical, digital and operational capabilities.".

On deck is Winjie Miao, who is currently senior executive vice president and chief operating officer. She's set for a promotion to president on April 5, priming her to step in as CEO in September when Berdan steps away. Miao has been Texas Health Resources' chief operating officer since 2022, but first joined the organization in 2000.

> Elisabeth Armstrong is the fresh chief of staff at the National Institutes of Health Office of the Director, filling in the void left with Seana Cranston's resignation earlier in March.

Armstrong, who has a doctorate in bioethics, comes from the Food and Drug Administration, where she served as director of the Office of the Executive Secretariat. Prior to joining government, she conducted healthcare policy equity research for Raymond James & Associates’ Global Equities and Investment, advised and held various ethics positions at biotech and healthcare organizations and was a broadcast journalist, among other roles.

> Cigna Healthcare, the insurance arm of the Cigna Group, announced that it named Stanley Crittenden, M.D., as its latest chief medical officer.

In the role, Crittenden will the lead the insurer's clinical operations, and will be tasked with partnering with other key leaders across the company to support the central goals of improving access and simplifying the healthcare journey for both patients and providers.

Crittenden brings years of experience in managed care, value-based care and population health to the role, Cigna stated in an announcement. He most recently served as CMO at Quantum Health, and also held leadership roles at Evergreen Nephrology, Anthem and Humana.

Crittenden is also board certified in internal medicine and nephrology, Cigna said.

In a recent development, “I’m honored to join Cigna Healthcare at this key moment in its transformation toward making health care simpler, more personalized and more affordable,” mentioned Crittenden in the announcement. “I am committed to fostering a collaborative and supportive environment, doing everything we can to improve the experience and outcomes of all those we serve.”.

> John Haupert, president and CEO of Atlanta-based Grady Health System, will be handing the reins over to current Chief Operating Officer Anthony Saul at the end of this year.

Sources indicate that saul is immediately claiming the president title, and will shuffle into the top spot on Jan. 1, 2027. Haupert will stick around through 2027 in an advisory role to soften the transition, support philanthropic and capital fundraising and provide strategic guidance on a latest $1+ billion medical campus the nonprofit also revealed this week.

In a recent development, haupert has headed Grady for the past 15 years. Saul has been around for seven, initially joining as chief financial officer.

> AI-powered prior authorization firm Humata Health is bringing Liz Fowler, former director of the Center for Medicare and Medicaid Innovation (CMMI), onto its board of directors.

The manufacturer said in an announcement that Fowler's experience at CMMI will support the team's efforts to accelerate Humata's mission to ensure patients get the care they need quickly. At CMMI, Fowler was tasked with rethinking reimbursement in Medicare and Medicaid to drive uptake of value-based care, providing critical insights she can bring to Humata.

Before her stint at CMMI, Fowler held leadership roles at the Commonwealth Fund and Johnson & Johnson. She currently serves as a distinguished scholar at the Johns Hopkins Bloomberg School of Public Health and the Carey Business School.

“Liz is a unicorn, a rare leader with deep experience in all realms of the healthcare ecosystem,” stated Jeremy Friese, M.D., Humata’s co-founder and CEO, in the announcement. “She understands the inherent complexities of the health system, and her expertise will be instrumental as we work toward our mission of solving these challenges.".

From her role driving innovation at CMMI to her track record of bipartisan work on federal health legislation, Liz’s experience will be an invaluable asset as we make AI-driven medical review a seamless process that ensures every patient receives the right care as rapidly as possible," Friese said.

> Jeff Balser, M.D., Ph.D., is retiring from his roles as CEO of Vanderbilt Health and dean of Vanderbilt University School of Medicine at the end of 2026.

The academic system's board of directors has kicked of a national search for a successor who would hold both titles, according to the March 12 announcement.

Sources indicate that A 1990 Vanderbilt graduate himself, Balser spent years as a cardiac anesthesiologist and surgical intensivist at Johns Hopkins before returning to Vanderbilt in 1998. He was named chair of the Department of Anesthesiology in 2001, dean of the medical school in 2008 and head of the Vanderbilt University Medical Center in 2009. He has served as dean and in the health system's top executive role for the past 17 years.

Recent findings suggest that the organization has grown from a four-hospital system to an eight-hospital system under his tenure, during which its annual net revenue also grew from around $2 billion to nearly $9 billion, according to the announcement. Part of that time was an effort he led to legally and financially separate the medical center and its system from the university as a standalone nonprofit. The organization's cash reserves also have also grown from 50 days to more than 110, with total cash on hand plus investments now exceeding $3 billion.

> Greg Hoffman, chief financial officer of Providence, will retire in June, the organization declared.

In a recent development, hoffman has been with the major nonprofit system for over a decade, and served as CFO for the past five years. His tenure in the role is marked by a multi-year financial turnaround that finally brought operations into the black during the quarter ended Sept. 30, 2025. The announcement of his retirement also pointed to his role striking up newly introduced strategic partnerships, resetting contracts with commercial payers and heading the implementation of an enterprise resource planning system.

Providence stated it aims to conduct an internal and national search for Hoffman's replacement.

> Kevin Tabb, M.D., president and CEO of Beth Israel Lahey Health, has given notice to the system's board that he plans to step down after this year.

It has been revealed that the physician executive was tapped as CEO of Beth Israel Deaconess in 2011, and stayed at the top through its merger with fellow Massachusetts provider Lahey Health in 2019. Today the organization spans 14 hospitals, employs 42,000 people and cares for 1.7 million patients annually.

It has been revealed that alongside navigating the merger and a pandemic, Tabb is credited with advancing initiatives around care access and connecting services delivered between its locations. Beth Israel Lahey also notched fresh partnerships: a teaching relationship with UMass Chan School of Medicine and an upcoming cancer collaboration with the Dana-Farber Cancer Institute.

Tabb will remain in his role while the system's board searches for his successor, a process expected to take about eight to 10 months, according to the announcement.

> Health tech company Stellar Health has added Raul Smith, a veteran of Elevance Health, as its chief financial officer.

In a recent development, smith has 20 years of experience in healthcare leadership, according to an announcement, including six years as president CFO for Anthem's East Region. He has also served as CFO for Duo Health and Gold Kidney Health Blueprint.

According to recent reports, stellar noted that Smith's experience in the health insurance industry will help the tech giant build out its platform. Stellar supports payers in value-based care by making it easier for providers to engage with these complex environments.

In addition, he'll play a key role in driving the financial evolution of its risk-based portfolio, including the tech-enabled accountable care organization, shaco.

"Stellar is already setting the pace for value-based care, and Raul adds the institutional caliber to match our growing scale," said Michael Meng, CEO and cofounder of Stellar Health. "Raul brings the financial authority to stand behind the definitive value we deliver to our payor partners. His leadership solidifies that our ROI is absolute and verifiable—impact that will only continue to compound and get better year over year.".

> Wellpoint Tennessee, an Elevance Health subsidiary, has named Rachel Chinetti as president of its health strategy.

As president, Chinetti will be tasked with leading the insurer's strategy and operations across the state, including a focus on affordability, access and quality for individuals enrolled in TennCare, its Medicaid program.

In a recent development, she brings almost two decades of experience in Medicaid and long-term services and supports (LTSS) to the role, per an announcement from the insurer. Chinetti has held multiple roles within TennCare and most recently served as a staff vice president within Elevance Health's government unit, where she led a center of excellence in LTSS.

Chinetti is also a native of the state who lives in Nashville, with strong community relationships, the manufacturer mentioned.

It has been revealed that “It is an honor to serve Tennesseans in this role,” Chinetti remarked in the release. “Wellpoint Tennessee has a strong legacy of partnership and innovation. I look forward to working alongside TennCare, providers, advocates, and community leaders to strengthen rural and maternal health, enhance long-term services and supports, and deliver more coordinated, person-centered care that helps our members live healthier, more independent lives.”.

Industry observers note that > James Downing, M.D., will be stepping down from his role as president and CEO of St. Jude Children's Research Hospital near the end of 2026, the pediatric research hospital announced.

The physician executive has been with the organization for four decades, and has sat at its head for the past 12 years. Under his leadership St. Jude underwent the largest strategic expansion in its history, which included the completion of two separate strategic intends requiring nearly $20 billion of investment and over 2,300 upcoming positions; major expansion to St. Jude's main campus; and greater international collaboration.

Prior to that he served as scientific director for eight years, a period in which he spearheaded the Pediatric Cancer Genome Project.

Downing plans to transition into a faculty role at St. Jude's Department of Global Pediatric Medicine after handing over the reins. The organization noted a replacement is expected to be named over the summer.

Recent findings suggest that “I’ve watched St. Jude transform the care of pediatric cancer around the world, and I’m grateful to have played a small part as its CEO," he remarked in the announcement. "It has been the honor of a lifetime to wake up every day and know that I have a purpose, to be a part of this workforce, and to change the outlook for children everywhere.”.

>The Department of Health and Human Services announced several leadership changes as the agency looks to advance Secretary Robert F. Kennedy Jr.'s Make American Healthy Again agenda.

HHS said that Chris Klomp will step into the role of chief counselor at the agency, where he will "oversee all operations of the department." Klomp right now serves as the director of Medicare.

In a recent development, in addition, both Politico and the Washington Post have reported that Jim O'Neill, deputy secretary of HHS and the acting director of the Centers for Disease Control and Prevention, will step down from both roles. Sources told the Post that O'Neill will be offered a position as an ambassador.

The Post reported that the shakeup comes amid significant controversy over the shift at HHS in vaccine policy and other hot-button topics. Kennedy is looking to shift talking points to more politically palatable topics, like healthy food, per the Post.

In addition to the newly introduced title for Klomp, Kennedy has tapped Kyle Diamantas and Grace Graham to serve as senior counselors for the Food and Drug Administration as well as John Brooks to step in as senior counselor for the Centers for Medicare & Medicaid Services.

HHS mentioned that each of these three will also continue to hold their current roles in addition to supporting Kennedy's office.

"I am proud to elevate battle-tested, principled leaders onto my immediate team—individuals with the courage and experience to help us move faster and go further as we work to Make America Healthy Again," Kennedy remarked in the press release.

>The Federation of American Hospitals revealed multiple leadership appointments this week.

The organization's new CEO, Charlene MacDonald, took the role on Jan. 1, and on Jan. 14, FAH revealed the names of key members of her team, including:.

Sources indicate that mcBride brings more than 25 years of overall healthcare experience to the COO role, including more than four years at FAH as its leading voice on patient safety, quality and public health. Broder has been at FAH for more than two years, and will take on an expanded role as chief strategy officer, spearheading efforts to support the organization's mission as well as its long-term stability and growth.

Recent findings suggest that keefe joined FAH in December 2024 and has more than two decades of policy experience, both at the state and federal levels. Tenoever will continue in the general counsel role, and has held similar titles at other trade associations, FAH noted.

Recent findings suggest that “Our exceptional new executive team will be integral to the Federation’s success as we write our next chapter,” MacDonald said in the announcement. “We’re at a critical moment for health care coverage and access, and our team’s proven ability to be strategic, nimble, and relentlessly solutions-oriented will allow the Federation to deliver for our members and the millions of patients they serve.”.

>Eduardo Conrado stepped into the CEO chair at Ascension on Jan. 1, taking over for the retiring Joseph Impicciche.

Conrado has been the major health system's president since 2023, and continues to hold that title. He joined in 2018 to serve in digital, strategy and innovation positions. Prior to that, he’d spent 26 years at Motorola Solutions and served on Ascension’s board for five years.

In a blog post published this week, Conrado remarked his focus as CEO will be for Ascension to strengthen access to care, modernize care delivery and deepen commitments to those most in need—achieved through a combination of mission-driven strategy, capital deployment and talent.

>Jesse Ehrenfeld, M.D., has joined clinical AI tech giant Aidoc as its latest chief medical officer.

In a recent development, ehrenfeld, a board-certified anesthesiologist and clinical informaticist, steps into the role after a stint as president of the American Medical Association. There, he led advocacy on issues like physician wellbeing and the responsible use of AI in clinical care. His new post will keep to those subjects as he supports Aidoc's health system customers.

“It’s clear that Aidoc’s success to date has been rooted in building technology physicians trust," he said in a release. "I’m joining to help scale that impact, ensuring that clinical AI continues to be a seamless, essential part of the modern care delivery model.”.

>Abhi Rastogi took on the roles of president and CEO at Temple Health on January 2, taking over for Michael Young, who retired.

Rastogi has been with the organization for more than 20 years. He most recently served as the president and CEO of Temple University Hospital and its campuses, as well as executive vice president and chief operating officer of the broader system. He's credited with delivering more than $100 million in annual impact via operational and financial improvements.

>Christian Pass was named chief financial officer of Keck Medicine of USC, and will officially begin the fresh role on Jan. 12.

He comes to the academic health system from Optum, where he was president of provider and payvider enterprise clients. Before that he had several senior financial leadership titles at John Muir Health that culminated in a chief financial officer role.

“Pass has more than 30 years of health care finance leadership experience with a proven history of cultivating high-performing teams and guiding organizations through critical financial and operational transformations,” Rod Hanners, CEO of Keck Medicine, stated in a release. “He brings tremendous knowledge and skill to this position that will support the continued growth of the health system.”.

Sources indicate that >Sarah Ness officially began her upcoming job as president and CEO of PeaceHealth on Jan. 3.

Sources indicate that ness has been with the nine-hospital system for more than 20 years, most recently as its executive vice president and chief administrative officer. She's credited with leading organizational transformations within the system's culture, technology systems and operations.

She takes over for Liz Dunne, who had announced her retirement last year.

>Chip Hubbs, the president CEO of Marysville, Ohio-based Memorial Health, shared intends to retire at the end of this year.

According to recent reports, he's held the roles for nearly 22 years, and before that was the CEO of Community Memorial Hospital elsewhere in the state. "In all, Chip has worked for nine different hospitals throughout his career in every facet from groundskeeper and maintenance to intern, fellow, Evening Administrator, Executive Director, and CEO," according to the announcement.

Hubbs plans to work with the health system's board on a long-term strategy and transition plan during his final year in the office.

In a recent development, >The Pharmaceutical Care Management Association, the lobbying group representing pharmacy benefit managers, has named longtime policy expert David Marin as its upcoming CEO, succeeding J.C. Scott.

Marin will officially take the CEO chair on Jan. 20, according to a PCMA announcement. He comes to the organization from drugmaker Viatris, where he was the global head of government affairs, public policy and advocacy. He also previously served as a managing principal at Podesta Group, where he led advocacy efforts for a slew of firms including the Blue Cross Blue Shield Association and Mylan.

He also held key staff roles on the Hill, according to the announcement.

“David Marin is the ideal leader for PCMA at a time of significant change in our industry,” said PCMA Board Chair Adam Kautzner, President of Express Scripts and Evernorth Care Management.

In addition to Marin's hire, PCMA announced that Brendan Buck will serve as the organization's upcoming chief communications officer, also effective on Jan. 20. Buck joins PCMA from public affairs firm Seven Letter.

→ Read original article